Emmanuelle Waubant, MD, PhD

Photo of Emmanuelle Waubant, MD, PhD
Title(s)Professor, Neurology
SchoolSchool of Medicine
Address675 Nelson Rising Lane
San Francisco CA 94158
ORCID ORCID Icon0000-0001-5188-0157 Additional info
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences


    Collapse Overview 
    Collapse overview
    Dr Waubant trained as a neurologist in Toulouse, France. She continued her training as a neuroimmunology fellow in Dr Stephen Hauser’s UCSF laboratory, focusing on matrix metalloproteinases (MMP) and their tissue inhibitors (TIMP), and their role in migration of lymphocytes through equivalents of the blood-brain barrier. In 1994, Dr Waubant returned to Toulouse to complete her 2-year junior faculty/chief residency in neurology. Dr Waubant later returned as a clinical research fellow at the UCSF MS Center with Dr Donald Goodkin. During that 3-year period, she furthered her in vitro MMP work to the study in the human disease that helped to understand the role of MMP-9 and TIMP-1 in patients with MS and their relationship to disease activity. After completing her clinical research training at the UCSF MS center, Dr Waubant returned to France to lead a clinical research center at Salpetriere Hospital in Paris for 2 years. She returned to the UCSF MS center in September 2001 as a faculty. She is also the Race to Erase MS Medical Director and coordinates clinical research collaborations between 8 American MS Centers of Excellence. With the support of the National MS Society, she has started a regional pediatric MS clinic at UCSF in January 2006 that she directs and has since seen over 500 patients with pediatric MS, NMO, MOG-associated disease or related disorders. She is the editor of the first text book on Pediatric MS and related disorders. In 2018, Dr Waubant funded an international group to foster diversity and visibility of women and minorities in the field of MS (International Women in MS, iwims.world). In March 2025, Dr Waubant became the president of the Americas Committee on Treatment and Research in MS (ACTRIMS, actrims.org). She is a member of the U.S. Pediatric MS Steering Committee. She is also chairing the international Clinical Trial Task Force for pediatric MS.
    Dr Waubant’s specific interests include the translation of promising agents from the bench to the bedside, understanding factors that predict the response to MS therapies, and risk factors for pediatric MS susceptibility and disease modification. She is the lead investigator for a trial of neuroprotection with N-acetyl cystein in progressive MS funded by the Department of Defense. Dr. Waubant is also a very active mentor for junior investigators.

    Collapse Biography 
    Collapse awards and honors
    Best Doctors in America2010Selected one of the "Best Doctors in America"
    UCSF2010Nominated for the Chancellor's Award for the Advancement of Women
    American Academy of Neurology2010Fellow of the American Academy of Neurology
    UCSF2010Nominated for the Outstanding Faculty Mentorship Award
    UCSF2008Nominated for the Outstanding Faculty Mentorship Award
    UCSF2011 Nominated for the Outstanding Faculty Mentorship Award
    UCSF2012 Nominated for the Outstanding Faculty Mentorship Award
    UCSF2013 Nominated for the Outstanding Faculty Mentorship Award
    American Neurological Association2013Fellow of the American Neurological Association
    International Women in MS2018Funder and Chair
    Americas Committee on Treatment and Research in MS2025President

    Collapse Research 
    Collapse Featured Publications
    Collapse research activities and funding
    Metabolic correlates of disease activity and disability progression in pediatric MS
    NIH R01NS117541Apr 1, 2021 - Mar 31, 2024
    Role: Principal Investigator
    Environmental and genetic risk factors for pediatric MS
    NIH R01NS071463Aug 15, 2010 - Apr 30, 2017
    Role: Principal Investigator
    Collapse Clinical Trials

    Collapse Featured Content 
    Collapse media links
    Collapse Mentoring
    Collapse Academic Senate

    Collapse Bibliographic 
    Collapse publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Impaired control of autoimmunity increases pediatric multiple sclerosis risk in EBNA-1-seropositives and -seronegatives. Proc Natl Acad Sci U S A. 2026 Oct 06; 123(40):e2607529123. Vietzen H, Waubant EL, Casper TC, Benson LA, Chitnis T, Schreiner T, Waldman AT, Mar S, Weinstock-Guttman B, Kühner LM, Berger SM, Graninger M, Rostásy K, Saucke H, Kauth F, Koukou G, Sommer S, Wendel EM, Bsteh G, Ponleitner M, Reindl M, Kornek B, Breu M, Puchhammer-Stöckl E, Rommer P, Berger T. PMID: 42821346; PMCID: PMC13643312.
      View in: PubMed   Mentions:
    2. Reduced Paramagnetic Rim Visibility Signals Lesion Aging and Tissue Degeneration in Progressive Multiple Sclerosis: Impact on Clinical Trials. Neurol Neuroimmunol Neuroinflamm. 2026 Nov; 13(6):e200655. Sacco S, Zhao H, Cheng S, Akula AV, Luskin E, Zhang J, Manouvakhova O, Cooper TP, Stern W, Block VJ, Virupakshaiah A, Gomez R, Santaniello A, Sati P, Papinutto N, Bove R, Gelfand JM, Goodin DS, Green AJ, Oksenberg J, Waubant E, Wilson MR, Zamvil SS, as the University of California, San Francisco MS-EPIC Team, Cree BAC, Hauser SL, Henry RG. PMID: 42766812.
      View in: PubMed   Mentions:
    3. Proportionality-based association metrics in count compositional data. NAR Genom Bioinform. 2026 Sep; 8(3):lqag102. McGregor K, Okaeme N, Khorasaniha R, Veniamin S, Jovel J, Miller R, Mahmood R, Graham M, Bonner C, Bernstein CN, Arnold DL, Bar-Or A, Marrie RA, O'Mahony J, Yeh EA, Zhao Y, Banwell B, Waubant E, Knox N, Van Domselaar G, Zhu F, Mirza AI, Tremlett H, Armstrong H. PMID: 42699185; PMCID: PMC13542730.
      View in: PubMed   Mentions:
    4. Longitudinal stability of dietary intake patterns in pediatric-onset multiple sclerosis: A multicenter prospective cohort study. Mult Scler Relat Disord. 2026 Aug 23; 115:107677. Virupakshaiah A, Schoeps VA, Chang G, Waltz M, Race J, Mar S, Francisco C, Casper TC, Rose J, Rodriguez M, Tillema JM, Chitnis T, Gorman MP, Benson LA, Graves JS, Rensel M, Abrams A, Krupp LB, O'Neill KA, Lotze TE, Aaen G, Wheeler Y, Schreiner T, Waldman AT, Chong J, Titcomb TJ, Tremlett H, Waubant E. PMID: 42697107.
      View in: PubMed   Mentions:
    5. Clinical Characteristics and Visual Outcomes of Optic Neuritis in Pediatric Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. J Neuroophthalmol. 2026 Aug 17. Abdul T, Nisanova A, Chopra A, Bugsch R, Virupakshaiah A, Kothapalli NP, Panse KM, Waubant E, Rasool N, Beres SJ, Liu YA. PMID: 42606014.
      View in: PubMed   Mentions:
    6. Interleukin 6 Receptor Blockade for Relapse Prevention in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. JAMA Neurol. 2026 Jul 13. Vilaseca A, Bilodeau PA, Gakis G, Savransky A, Mahler Ferreira Oliveira J, Nguyen L, Hooshmand SI, Satyanarayan S, Moseley CE, Haley L, Roy-Hewitson C, Marrodan M, Casallas A, Manin A, Chen H, Hoshina Y, Grzezulkowska A, Carnero Contentti E, Galleguillos L, Upchurch M, Jackson-Tarlton CS, Chu-Yueh Guo J, Fabian M, Virupakshaiah A, Arrambide G, Caparó-Zamalloa C, Paterno R, Waubant E, Ordoñez Boschetti L, Correale J, Villa AM, Banwell B, Marignier R, Pittock SJ, Greenberg B, Bennett JL, Cho T, Clardy S, Solomon AJ, Kister I, Zamvil SS, Gelfand JM, Repovic P, Obeidat AZ, Blackburn K, Tenembaum S, Chen JJ, Sotirchos ES, Levy M, Flanagan EP, and The Americas MOGAD Treatment Group, Murillo F, Syc-Mazurzek SB, Cacciaguerra L, Jiang M, da Silva Rezende NB, Wingerchuk DM, Horsman SE. PMID: 42440328; PMCID: PMC13366257.
      View in: PubMed   Mentions:    Fields:    
    7. Exploring Healthcare Continuity in Pediatric-Onset Multiple Sclerosis in the United States. Ann Child Neurol Soc. 2026 Sep; 4(3):177-187. Abrams AW, Waltz M, Race J, Casper TC, Gambrah-Lyles C, O'Neill K, Virupakshaiah A, Fisher KS, Wright MA, Poisson KE, Bernfeld EM, Aaen G, Benson LA, Chitnis T, Francisco C, Gombolay GY, Gorman MP, Graves JS, Krupp L, Lotze TE, Mar S, Ness J, Rensel M, Rodriguez M, Schreiner T, Shukla N, Tillema JM, Weinstock-Guttman B, Wheeler Y, Waubant E, Rose J, US Network of Pediatric MS Centers. PMID: 42751265; PMCID: PMC13580349.
      View in: PubMed   Mentions:
    8. Application of the 2024 McDonald Criteria in Individuals With Nonspecific Symptoms or Incidental Imaging Findings in a Multicenter Study. Neurology. 2026 Jul 14; 107(1):e218183. Scharf A, Cohen JA, Marrie RA, Miller AE, Waubant E, Kilbane M, Luskin E, Azevedo CJ, Dever M, Alvarez E, Calabresi PA, Chahin S, Freeman L, Nakamura K, Longbrake EE, Mowry EM, Oh J, Rodrigues PR, Ramos M, Sotirchos ES, Cutter GR, Kaisey M, Amin M, Toljan K, Illenberger N, Bilello M, Lee J, Maya M, Obusez EC, Schindler MK, Suthiphosuwan S, Ulano A, Shinohara RT, Reich DS, Solomon AJ, Sicotte NL, Sati P, Ontaneda D. PMID: 42284534; PMCID: PMC13267864.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. High-dose N-acetyl cysteine reduces GFAP levels: Exploratory results from a pilot double-blind, placebo-controlled randomized trial. Mult Scler. 2026 Jun 11; 13524585261454840. Schoeps VA, Murataj R, Virupakshaiah A, Moseley CE, Krysko KM, Nourbakhsh B, Qureshi F, Henry R, Waubant E. PMID: 42273981.
      View in: PubMed   Mentions:    Fields:    
    10. Adenotonsillectomy is associated with increased risk and disease activity in pediatric-onset multiple sclerosis. Mult Scler. 2026 Sep; 32(10):1014-1021. Chang G, Nasr Z, Schoeps VA, Virupakshaiah A, Zamvil SS, Moseley CE, Sabatino JJ, Chong J, Graves JS, Waltz M, Rodriguez M, Tillema JM, Chitnis T, Rensel M, Abrams AW, Krupp L, Waldman AT, Mar S, Schreiner T, Rose J, Casper TC, Waubant E. PMID: 42212792; PMCID: PMC13225604.
      View in: PubMed   Mentions:    Fields:    
    11. Epstein-Barr Virus Antibodies to Differentiate Multiple Sclerosis From Other Neuroinflammatory Diseases. JAMA Neurol. 2026 May 01; 83(5):461-470. Vietzen H, Kühner LM, Berger SM, Reinecke R, Rostásy K, Saucke H, Kauth F, Koukou G, Sommer S, Wendel EM, Graninger M, Camp JV, Waubant EL, Casper TC, Benson LA, Chitnis T, Aaen GS, Mar S, Weinstock-Guttman B, Lotze TE, Krupp LB, Lassmann H, Weidner L, Pistorius C, Jungbauer C, Ponleitner M, Reindl M, Kornek B, Breu M, Bsteh G, Höftberger R, Berger T, Puchhammer-Stöckl E, Rommer P. PMID: 41801194; PMCID: PMC12973216.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    12. The gut microbiome in pediatric-onset acquired demyelinating syndromes by myelin oligodendrocyte glycoprotein antibody status. Mult Scler Relat Disord. 2026 Jun; 110:107216. Tsai W, Zhu F, Bar-Or A, Bernstein CN, Bonner C, Graham M, Marrie RA, Mirza AI, O'Mahony J, Yeh EA, Banwell B, Waubant E, Tremlett H, Canadian Pediatric Demyelinating Disease Network. PMID: 42068931.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Higher ultra-processed food consumption is associated with higher likelihood of paediatric-onset multiple sclerosis. Mult Scler Relat Disord. 2026 May; 109:107159. Machado P, Mazahery H, Black LJ, Tremlett H, Daly A, Pham NM, Tessema GA, Zhu F, Banwell B, Bar-Or A, Marrie RA, Bernstein CN, Mirza AI, Yeh EA, Waubant E, O'Mahony J, Dunlop E, Canadian Demyelinating Disease Network. PMID: 41916081.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. Telomere length as a marker of biological age in paediatric multiple sclerosis. J Neurol Neurosurg Psychiatry. 2026 Mar 13; 97(4):302-308. Jacques K, Race J, Goyne C, Fair A, Schuette A, Yang JH, Caillier S, Aaen GS, Abrams A, Benson L, Casper TC, Chitnis T, Gorman MP, Lotze T, Krupp L, Mar S, Ness J, Rensel M, Rodriguez M, Rose J, Schreiner T, Tillema JM, Waldman A, Wheeler Y, Oksenberg J, Lin J, Waubant E, Graves JS. PMID: 41500800; PMCID: PMC13292612.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    15. Accelerated metabolomic aging and its association with social determinants of health in multiple sclerosis. Mult Scler. 2026 Apr; 32(4):421-428. Siavoshi F, Noroozi R, Chang G, Schoeps VA, Smith MD, Briggs FB, Graves JS, Waubant E, Mowry EM, Calabresi PA, Bhargava P, Fitzgerald KC. PMID: 41718456; PMCID: PMC12927593.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Investigating the Frequency and Outcome of Central Vein Sign and Paramagnetic Rim Lesions in Children With MOGAD. Neurology. 2026 Feb 10; 106(3):e214410. Nistri R, Cacciaguerra L, Sacco S, Virupakshaiah A, De Meo E, Papinutto N, Henry RG, Meirson H, Hemingway C, Rossor T, Wassmer E, Bensira L, Pratt LT, Biswas A, Sudhakar S, Mankad K, Chen JJ, Pittock SJ, Barkhof F, Ciccarelli O, Waubant E, Flanagan EP, Hacohen Y. PMID: 41512208; PMCID: PMC12805584.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Epigenetic age and telomere length correlations in pediatric-onset multiple sclerosis. Mult Scler. 2025 Dec; 31(14):1641-1650. Yang JH, Race J, Sumowski P, Jacques K, Fardad S, Fair A, Hazlett A, Lin J, Yilmaz D, Aaen G, Abrams A, Benson L, Casper TC, Chitnis T, Gorman M, Lotze T, Krupp L, Mar S, Ness J, Rensel M, Rose J, Schreiner T, Tillema JM, Waldman A, Wheeler Y, Barcellos LF, Waubant E, Graves JS. PMID: 41195728; PMCID: PMC12614491.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    18. Real-World Effectiveness of Switching to Oral or Infusion Versus Injectable Disease-Modifying Therapy in Pediatric Multiple Sclerosis. Ann Neurol. 2026 03; 99(3):715-729. Abrams AW, Waltz M, Casper TC, Aaen G, Benson LA, Bernfeld EM, Charvet LE, Chitnis T, Francisco C, Gorman MP, Graves JS, Krupp L, O'Neill K, Lotze TE, Mar S, Ness J, Rensel M, Rodriguez M, Rose J, Rutatangwa A, Schreiner T, Shukla N, Tillema JM, Weinstock-Guttman B, Wheeler Y, Waubant E, Krysko KM, US Network of Pediatric MS Centers. PMID: 41195640; PMCID: PMC12954145.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    19. Finite-course ocrelizumab in relapsing multiple sclerosis: Results of two prospective open-label trials with matched controls. Mult Scler. 2025 Oct; 31(11):1338-1347. Salazar-Camelo A, Vega L, Fadlallah Y, Bou Rjeily N, Balshi A, Morris B, Ghajarzadeh M, Mowry EM, Waubant E, Nourbakhsh B. PMID: 40970353.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    20. Cognitive Function in People With Pediatric Multiple Sclerosis Over 2 Years. Neurology. 2025 Oct 21; 105(8):e214142. O'Neill KA, Charvet L, Waltz M, George A, Benson LA, Gorman MP, Mar SS, Ness JM, Schreiner T, Waubant E, Weinstock-Guttman B, Wheeler YS, Abrams AW, Chitnis T, Rodriguez M, Rose JW, Tillema JM, Virupakshaiah A, Casper TC, Krupp LB, US Network of Pediatric MS Centers. PMID: 40966491.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Evaluating Efficacy Outcomes in Pediatric Multiple Sclerosis Patients While Using Avonex or Plegridy via USNPMSC Registry. J Child Neurol. 2026 04; 41(4):545-555. Wright MA, Barney BJ, Peterson S, Waltz M, Rose J, Rensel M, Abrams A, Waubant E, Wheeler Y, Rodriguez M, Tillema JM, Krupp L, Gorman M, Benson L, Lotze T, Shukla N, Mar S, Chitnis T, Schreiner T, Vignos M, Casper TC. PMID: 40956912; PMCID: PMC13018251.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    22. Smouldering disease in paediatric-onset multiple sclerosis. EBioMedicine. 2025 Oct; 120:105921. Filippi M, Margoni M, Banwell B, Chitnis T, Dale R, Fadda G, Hacohen Y, Krupp LB, Preziosa P, Yeh EA, Waubant E, Rocca MA. PMID: 40939291; PMCID: PMC12571582.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    23. High-Dose Pulse Glucocorticoid Treatment Prevents White Matter Spinal Cord Pseudoatrophy in Newly Diagnosed Multiple Sclerosis. Ann Neurol. 2025 10; 98(4):837-850. Sacco S, Papinutto N, Schoeps VA, Cheng S, Stern WA, Zhao H, Bischof A, Caverzasi E, Dombagahawatta M, Juwono J, Akula A, Cordano C, Beaudry-Richard A, Gomez R, Harms M, Santaniello A, Bove RM, Gelfand JM, Goodin DS, Green AJ, Oksenberg JR, Waubant E, Wilson MR, Zamvil SS, Cree BAC, Hauser SL, Henry RG. PMID: 40552528; PMCID: PMC12542327.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    24. Epigenetic Aging in Pediatric-Onset Multiple Sclerosis. Neurology. 2025 Jun 24; 104(12):e213673. Goyne C, Fair AE, Yilmaz D, Race J, Schuette A, Caillier SJ, Aaen GS, Abrams AW, Benson LA, Casper TC, Chitnis T, Gorman MP, Lotze TE, Krupp LB, Mar SS, Ness JM, Rensel M, Rodriguez M, Rose JW, Schreiner TL, Tillema JM, Waldman AT, Wheeler YS, Barcellos LF, Waubant E, Graves JS, as the US Network of Pediatric MS Centers. PMID: 40460354; PMCID: PMC12141422.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    25. Allele-specific vitamin D receptor binding is associated with pediatric-onset multiple sclerosis. Mult Scler J Exp Transl Clin. 2025 Apr-Jun; 11(2):20552173251335625. Yilmaz D, Adams C, Horton MK, Graves JS, Francisco C, Edwards A, Quach H, Quach D, Aaen G, Lotze T, Mar S, Ness J, Wheeler Y, Gorman MP, Benson L, Weinstock-Guttman B, Waldman A, Schreiner T, Tillema JM, Chitnis T, Rose J, Casper TC, Rensel M, Waubant E, Barcellos LF, Network of Pediatric Multiple Sclerosis Centers. PMID: 40438528; PMCID: PMC12117238.
      View in: PubMed   Mentions:
    26. Accelerated Metabolomic Aging and Its Association with Social Determinants of Health in Multiple Sclerosis. medRxiv. 2025 May 05. Siavoshi F, Noroozi R, Chang G, Schoeps VA, Smith MD, Briggs FBS, Graves JS, Waubant E, Mowry EM, Calabresi PA, Bhargava P, Fitzgerald KC. PMID: 39974014; PMCID: PMC11838630.
      View in: PubMed   Mentions: 1  
    27. Childhood adversity in parents of patients with pediatric multiple sclerosis. Mult Scler Relat Disord. 2025 Jun; 98:106424. O'Neill KA, Charvet L, George A, Waltz M, Casper TC, Benson L, Gorman M, Mar S, Ness J, Schreiner T, Waubant E, Weinstock-Guttman B, Wheeler Y, Ortiz R, Krupp LB, United States Network of Pediatric MS Centers. PMID: 40215565.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    28. Limited early IVIG for the treatment of pediatric myelin oligodendrocyte glycoprotein antibody-associated disease. Mult Scler Relat Disord. 2025 May; 97:106345. MacRae R, Race J, Schuette A, Waltz M, Casper TC, Rose J, Abrams A, Rensel M, Waubant E, Virupakshaiah A, Schoeps V, O'Neill K, Ness J, Wheeler Y, Shukla N, Mar S, Rodriguez M, Chitnis T, Gorman M, Benson L. PMID: 40088722.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    29. Association Between Sun Exposure and Risk of Relapse in Pediatric-Onset Multiple Sclerosis. Neurol Neuroimmunol Neuroinflamm. 2025 Mar; 12(2):e200375. Chang G, Sebastian P, Virupakshaiah A, Schoeps VA, Cherbuin N, Casper TC, Gorman MP, Benson LA, Chitnis T, Rensel M, Abrams AW, Lotze T, Mar SS, Schreiner TL, Wheeler YS, Rose JW, Graves J, Krupp LB, Waldman AT, Lucas R, Waubant E, as the US Network of Pediatric Multiple Sclerosis Centers. PMID: 39938013; PMCID: PMC11820808.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    30. Study of the Association Between Menarche and Disease Course in Pediatric Multiple Sclerosis. Neurology. 2025 Feb 25; 104(4):e210213. Krysko KM, Waltz M, Chitnis T, Weinstock-Guttman B, Aaen GS, Belman A, Benson LA, Gorman MP, Lotze TE, Mar SS, Moodley M, Ness JM, Rensel M, Rodriguez M, Rose JW, Edwards AR, Schreiner TL, Wheeler YS, Barney BJ, Waubant E, Casper TC, Graves JS, as the US Network of Pediatric MS Centers. PMID: 39899789.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    31. Distinct plasma lipids predict axonal injury and multiple sclerosis activity. J Neurol Neurosurg Psychiatry. 2025 Jan 16; 96(2):150-157. Schoeps VA, Bhargava P, Virupakshaiah A, Ladakis DC, Moseley C, Chong J, Aaen G, Graves JS, Benson L, Gorman MP, Rensel M, Abrams A, Mar S, Lotze TE, Chitnis T, Waldman A, Krupp L, Rodriguez M, Tillema JM, Rose J, Schreiner T, Qureshi F, Peterson S, Barcellos LF, Casper TC, Newman J, Borkowski K, Waubant E, US Network of Pediatric MS Centers. PMID: 39266284.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    32. Ocrelizumab dose selection for treatment of pediatric relapsing-remitting multiple sclerosis: results of the OPERETTA I study. J Neurol. 2025 Jan 15; 272(2):137. Mar S, Valeriani M, Steinborn B, Schreiner T, Waubant E, Filippi M, Kotulska K, Mazurkiewicz-Beldzinska M, El Azzouzi B, Lin CJ, Shen YA, Kletzl H, Evershed J, Hogea A, Manlius C, Bonati U, Banwell B. PMID: 39812825; PMCID: PMC11735518.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    33. Restoring the Multiple Sclerosis Associated Imbalance of Gut Indole Metabolites Promotes Remyelination and Suppresses Neuroinflammation. bioRxiv. 2025 Jan 13. Jank L, Singh SS, Lee J, Dhukhwa A, Siavoshi F, Joshi D, Minney V, Gupta K, Ghimire S, Deme P, Schoeps VA, Soman K, Ladakis D, Smith M, Borkowski K, Newman J, Baranzini SE, Waubant EL, Fitzgerald KC, Mangalam A, Haughey N, Kornberg M, Chamling X, Calabresi PA, Bhargava P. PMID: 39554063; PMCID: PMC11565924.
      View in: PubMed   Mentions: 1  
    34. The observation of seasonal variation of fatigue in multiple sclerosis depends on the measurement instrument. Mult Scler Relat Disord. 2025 Feb; 94:106252. Cordano C, Waubant E, Nourbakhsh B. PMID: 39742689.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    35. The fungal gut microbiota in pediatric-onset multiple sclerosis. Front Microbiol. 2024; 15:1258978. Mok N, Knox NC, Zhu F, Arnold DL, Bar-Or A, Bernstein CN, Bonner C, Forbes JD, Graham M, Marrie RA, O'Mahony J, Yeh EA, Zhao Y, Van Domselaar G, Banwell B, Waubant E, Tremlett HL. PMID: 39744394; PMCID: PMC11688249.
      View in: PubMed   Mentions: 3  
    36. Predictors of a relapsing course in myelin oligodendrocyte glycoprotein antibody-associated disease. J Neurol Neurosurg Psychiatry. 2024 12 16; 96(1):68-75. Virupakshaiah A, Schoeps VA, Race J, Waltz M, Sharayah S, Nasr Z, Moseley CE, Zamvil SS, Gaudioso C, Schuette A, Casper TC, Rose J, Flanagan EP, Rodriguez M, Tillema JM, Chitnis T, Gorman MP, Graves JS, Benson LA, Rensel M, Abrams A, Krupp L, Lotze TE, Aaen G, Wheeler Y, Schreiner T, Waldman A, Chong J, Mar S, Waubant E. PMID: 38964848; PMCID: PMC11652255.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    37. Epidemiology and Impact of Social Hardships in Children With Multiple Sclerosis in the United States. Neurology. 2024 Dec 10; 103(11):e209991. Wilson E, Meeks HD, Barney BJ, Waltz M, Canenguez K, Casper TC, Rose JW, Rodriguez M, Tillema JM, Chitnis T, Gorman MP, Rensel M, Abrams AW, Krupp LB, Lotze TE, Fisher KS, Shukla NM, Schreiner TL, Mar SS, Waubant E, Virupakshaiah A, Wheeler YS, Ness JM, Benson LA, as the United States Network of Pediatric Multiple Sclerosis Centers. PMID: 39531607.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    38. Differential Diagnosis of Suspected Multiple Sclerosis in Pediatric and Late-Onset Populations: A Review. JAMA Neurol. 2024 Sep 16. Hua LH, Solomon AJ, Tenembaum S, Scalfari A, Rovira À, Rostasy K, Newsome SD, Marrie RA, Magyari M, Kantarci O, Hemmer B, Hemingway C, Harnegie MP, Graves JS, Cohen JA, Bove R, Banwell B, Corboy JR, Waubant E. PMID: 39283621.
      View in: PubMed   Mentions: 2     Fields:    
    39. Early Adversity and Socioeconomic Factors in Pediatric Multiple Sclerosis: A Case-Control Study. Neurol Neuroimmunol Neuroinflamm. 2024 09; 11(5):e200282. Jensen SKG, Camposano S, Berens A, Waltz M, Krupp LB, Charvet L, Belman AL, Aaen GS, Benson LA, Candee M, Casper TC, Chitnis T, Graves J, Wheeler YS, Kahn I, Lotze TE, Mar SS, Rensel M, Rodriguez M, Rose JW, Rubin JP, Tillema JM, Waldman AT, Weinstock-Guttman B, Barcellos LF, Waubant E, Gorman MP, US Network of Pediatric Multiple Sclerosis Centers. PMID: 39146511; PMCID: PMC11379435.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    40. Mediterranean diet and associations with the gut microbiota and pediatric-onset multiple sclerosis using trivariate analysis. Commun Med (Lond). 2024 Jul 19; 4(1):148. Mirza AI, Zhu F, Knox N, Black LJ, Daly A, Bonner C, Van Domselaar G, Bernstein CN, Marrie RA, Hart J, Yeh EA, Bar-Or A, O'Mahony J, Zhao Y, Hsiao W, Banwell B, Waubant E, Tremlett H. PMID: 39030379; PMCID: PMC11271616.
      View in: PubMed   Mentions: 12  
    41. Central vein sign and trigeminal lesions of multiple sclerosis visualised by 7T MRI. J Neurol Neurosurg Psychiatry. 2024 07 15; 95(8):761-766. Jing J, Zhang Z, Su L, Gao C, Guo A, Liu X, Wang H, Zhang X, Liu Y, Comi G, Waubant E, Shi FD, Tian DC. PMID: 38453475; PMCID: PMC11287640.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    42. Increased intraindividual variability (IIV) in reaction time is the earliest indicator of cognitive change in MS: A two-year observational study. Int J Clin Health Psychol. 2024 Jul-Sep; 24(3):100486. Pilloni G, Casper TC, Mar S, Ness J, Schreiner T, Waltz M, Waubant E, Weinstock-Guttman B, Wheeler Y, Krupp L, Charvet L. PMID: 39105175; PMCID: PMC11299566.
      View in: PubMed   Mentions: 1  
    43. MOG CNS Autoimmunity and MOGAD. Neurol Neuroimmunol Neuroinflamm. 2024 Sep; 11(5):e200275. Moseley CE, Virupakshaiah A, Forsthuber TG, Steinman L, Waubant E, Zamvil SS. PMID: 38996203; PMCID: PMC11256982.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansAnimals
    44. Association of nutritional intake with clinical and imaging activity in pediatric multiple sclerosis. Mult Scler. 2024 Jul; 30(8):1056-1065. Mohan SD, Peterson S, Brenton JN, Carmichael SL, Virupakshaiah A, Rodriguez M, Tillema JM, Mar S, Rensel MR, Abrams A, Chitnis T, Benson L, Gorman M, Lotze T, Shukla N, Graves J, Aaen G, Casper TC, Waubant E. PMID: 39078111; PMCID: PMC11404351.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    45. Unveiling the Performance of Proposed MOGAD Diagnostic Criteria. Neurology. 2024 07 09; 103(1):e209551. Schoeps VA, Virupakshaiah A, Waubant E. PMID: 38870485.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    46. Clinical and magnetic resonance imaging outcomes in pediatric-onset MS patients on fingolimod and ocrelizumab. Mult Scler Relat Disord. 2024 Jul; 87:105647. Nasr Z, Casper TC, Waltz M, Virupakshaiah A, Lotze T, Shukla N, Chitnis T, Gorman M, Benson LA, Rodriguez M, Tillema JM, Krupp L, Schreiner T, Mar S, Rensel M, Rose J, Liu C, Guye S, Manlius C, Waubant E, U.S. Network of Pediatric Multiple Sclerosis Centers. PMID: 38838422.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    47. Life-Threatening MOG Antibody-Associated Hemorrhagic ADEM With Elevated CSF IL-6. Neurol Neuroimmunol Neuroinflamm. 2024 Jul; 11(4):e200243. Virupakshaiah A, Moseley CE, Elicegui S, Gerwitz LM, Spencer CM, George E, Shah M, Cree BAC, Waubant E, Zamvil SS. PMID: 38630950; PMCID: PMC11087044.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    48. Assessment of dietary intake and its inflammatory potential in persons with pediatric-onset multiple sclerosis. Mult Scler Relat Disord. 2024 Jun; 86:105599. Bitarafan S, Zhu F, Mirza A, Bernstein CN, Van Domselaar G, Marrie RA, Yeh EA, Zhao Y, Banwell B, Waubant E, Tremlett H. PMID: 38604004.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    49. Gene-environment interactions: Epstein-Barr virus infection and risk of pediatric-onset multiple sclerosis. Mult Scler. 2024 Mar; 30(3):308-315. Ziaei A, Solomon O, Casper TC, Waltz M, Weinstock-Guttman B, Aaen G, Wheeler Y, Graves J, Benson L, Gorman M, Rensel M, Mar S, Lotze T, Greenberg B, Chitnis T, Waldman AT, Krupp L, James JA, Hart J, Barcellos LF, Waubant E. PMID: 38332747; PMCID: PMC11093131.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    50. Clinical and Imaging Findings in Children with Myelin Oligodendrocyte Glycoprotein Antibody Associated Disease (MOGAD): From Presentation to Relapse. AJNR Am J Neuroradiol. 2024 02 07; 45(2):229-235. George E, Russ JB, Validrighi A, Early H, Mamlouk MD, Glenn OA, Francisco CM, Waubant E, Lindan C, Li Y. PMID: 38176731; PMCID: PMC11285982.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    51. Design recommendations for studies that evaluate multiple sclerosis fatigue interventions. Front Psychiatry. 2023; 14:1287344. Ghajarzadeh M, Waubant E, Nourbakhsh B. PMID: 38268567; PMCID: PMC10805898.
      View in: PubMed   Mentions: 1  
    52. A cross-sectional study of MRI features and the gut microbiome in pediatric-onset multiple sclerosis. Ann Clin Transl Neurol. 2024 02; 11(2):486-496. Zhu F, Zhao Y, Arnold DL, Bar-Or A, Bernstein CN, Bonner C, Graham M, Hart J, Knox N, Marrie RA, Mirza AI, O'Mahony J, Van Domselaar G, Yeh EA, Banwell B, Waubant E, Tremlett H, US Network of Pediatric MS Centers, the Canadian Pediatric Demyelinating Disease Network. PMID: 38130033; PMCID: PMC10863907.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    53. Gene-environment interactions and risk of pediatric-onset multiple sclerosis associated with time spent outdoors. Mult Scler Relat Disord. 2024 Feb; 82:105351. Nasr Z, Virupakshaiah A, Schoeps VA, Cherbuin N, Casper TC, Waltz M, Hart J, Rodriguez M, Gorman MP, Benson LA, Chitnis T, Rensel M, Abrams A, Krupp L, Waldman AT, Lotze T, Aaen GS, Mar S, Schreiner T, Wheeler Y, Rose J, Shukla NM, Barcellos LF, Lucas R, Waubant E. PMID: 38141560.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    54. Short-chain fatty acid producers in the gut are associated with pediatric multiple sclerosis onset. Ann Clin Transl Neurol. 2024 01; 11(1):169-184. Schoeps VA, Zhou X, Horton MK, Zhu F, McCauley KE, Nasr Z, Virupakshaiah A, Gorman MP, Benson LA, Weinstock-Guttman B, Waldman A, Banwell BL, Bar-Or A, Marrie RA, van Domselaar G, O'Mahony J, Mirza AI, Bernstein CN, Yeh EA, Casper TC, Lynch SV, Tremlett H, Baranzini S, Waubant E, US Network of Pediatric MS Centers. PMID: 37955284; PMCID: PMC10791026.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    55. Susceptibility-based imaging aids accurate distinction of pediatric-onset MS from myelin oligodendrocyte glycoprotein antibody-associated disease. Mult Scler. 2023 12; 29(14):1736-1747. Sacco S, Virupakshaiah A, Papinutto N, Schoeps VA, Akula A, Zhao H, Arona J, Stern WA, Chong J, Hart J, Zamvil SS, Sati P, Henry RG, Waubant E. PMID: 37897254; PMCID: PMC10687802.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    56. Characteristics and predictors of disease course in children initially presenting with ADEM. Mult Scler Relat Disord. 2023 Oct 15; 80:105075. Rutatangwa A, Aaen G, Krysko KM, Belman A, Benson LA, Chitnis T, Gorman M, Goyal M, Graves JS, Wheeler Y, Krupp L, Lotze T, Mar S, Ness J, Rensel M, Rodriguez M, Rose J, Schreiner T, Tillema JM, Weinstock-Guttman B, Waltz M, Casper TC, Waubant E, U.S. Network of Pediatric MS Centers. PMID: 39491412.
      View in: PubMed   Mentions:    Fields:    
    57. Differential diagnosis of suspected multiple sclerosis: an updated consensus approach. Lancet Neurol. 2023 08; 22(8):750-768. Solomon AJ, Arrambide G, Brownlee WJ, Flanagan EP, Amato MP, Amezcua L, Banwell BL, Barkhof F, Corboy JR, Correale J, Fujihara K, Graves J, Harnegie MP, Hemmer B, Lechner-Scott J, Marrie RA, Newsome SD, Rocca MA, Royal W, Waubant EL, Yamout B, Cohen JA. PMID: 37479377.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    58. Serum neurofilament light chain reference database for individual application in paediatric care: a retrospective modelling and validation study. Lancet Neurol. 2023 09; 22(9):826-833. Abdelhak A, Petermeier F, Benkert P, Schädelin S, Oechtering J, Maleska Maceski A, Kabesch M, Geis T, Laub O, Leipold G, Gobbi C, Zecca C, Green A, Tumani H, Willemse E, Wiendl H, Granziera C, Kappos L, Leppert D, Waubant E, Wellmann S, Kuhle J. PMID: 37524100.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    59. Several serum lipid metabolites are associated with relapse risk in pediatric-onset multiple sclerosis. Mult Scler. 2023 07; 29(8):936-944. Virupakshaiah A, Ladakis DC, Nourbakhsh B, Bhargava P, Dilwali S, Schoeps V, Borkowski K, Newman JW, Waubant E. PMID: 37199529; PMCID: PMC10524330.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    60. Demographic Features and Clinical Course of Patients With Pediatric-Onset Multiple Sclerosis on Newer Disease-Modifying Treatments. Pediatr Neurol. 2023 08; 145:125-131. Malani Shukla N, Casper TC, Ness J, Wheeler Y, Chitnis T, Lotze T, Gorman M, Benson L, Weinstock-Guttmann B, Aaen G, Rodriguez M, Tillema JM, Krupp L, Schreiner T, Mar S, Goyal M, Rensel M, Abrams A, Rose J, Waltz M, Liu T, Manlius C, Waubant E, U.S. Network of Pediatric Multiple Sclerosis Centers. PMID: 37348193.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    61. High-dose vitamin D3 supplementation in relapsing-remitting multiple sclerosis: a randomised clinical trial. EClinicalMedicine. 2023 May; 59:101957. Cassard SD, Fitzgerald KC, Qian P, Emrich SA, Azevedo CJ, Goodman AD, Sugar EA, Pelletier D, Waubant E, Mowry EM. PMID: 37125397; PMCID: PMC10130605.
      View in: PubMed   Mentions: 19  
    62. High serum neurofilament levels are observed close to disease activity events in pediatric-onset MS and MOG antibody-associated diseases. Mult Scler Relat Disord. 2023 Jun; 74:104704. Ziaei A, Nasr Z, Hart J, Francisco C, Rutatangwa A, Leppert D, Kuhle J, Flanagan E, Waubant E. PMID: 37031551.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    63. A Phase 1 Study of Oral Vitamin D3 in Boys and Young Men With X-Linked Adrenoleukodystrophy. Neurol Genet. 2023 Apr; 9(2):e200061. Van Haren KP, Cunanan K, Awani A, Gu M, Peña D, Chromik LC, Považan M, Rossi NC, Goodman J, Sundaram V, Winterbottom J, Raymond GV, Cowan T, Enns GM, Waubant E, Steinman L, Barker PB, Spielman D, Fatemi A. PMID: 37090939; PMCID: PMC10117697.
      View in: PubMed   Mentions: 3  
    64. Characteristics of pediatric patients with multiple sclerosis and related disorders infected with SARS-CoV-2. Mult Scler. 2023 04; 29(4-5):576-584. Schreiner T, Wilson-Murphy M, Mendelt-Tillema J, Waltz M, Codden R, Benson L, Gorman M, Goyal M, Krupp L, Lotze T, Mar S, Ness J, Rensel M, Roalstad S, Rodriguez M, Rose J, Shukla N, Waubant E, Wheeler Y, Casper TC, Chitnis T. PMID: 36960480; PMCID: PMC10040482.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    65. Silent findings: Examination of asymptomatic demyelination in a pediatric US cohort. Mult Scler Relat Disord. 2023 Mar; 71:104573. Bhise V, Waltz M, Casper TC, Aaen G, Benson L, Chitnis T, Gorman M, Goyal MS, Wheeler Y, Lotze T, Mar S, Rensel M, Abrams A, Rodriguez M, Rose J, Schreiner T, Shukla N, Waubant E, Weinstock-Guttman B, Ness J, Krupp L, Mendelt-Tillema J, U.S. Network of Pediatric Multiple Sclerosis Centers. PMID: 36871372.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    66. Rare and low-frequency coding genetic variants contribute to pediatric-onset multiple sclerosis. Mult Scler. 2023 04; 29(4-5):505-511. Horton MK, Shim JE, Wallace A, Graves JS, Aaen G, Greenberg B, Mar S, Wheeler Y, Weinstock-Guttman B, Waldman A, Schreiner T, Rodriguez M, Tillema JM, Chitnis T, Krupp L, Casper TC, Rensel M, Hart J, Quach HL, Quach DL, Schaefer C, Waubant E, Barcellos LF. PMID: 36755464; PMCID: PMC10149552.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    67. Gene-environment interactions increase the risk of paediatric-onset multiple sclerosis associated with household chemical exposures. J Neurol Neurosurg Psychiatry. 2023 07; 94(7):518-525. Nasr Z, Schoeps VA, Ziaei A, Virupakshaiah A, Adams C, Casper TC, Waltz M, Rose J, Rodriguez M, Tillema JM, Chitnis T, Graves JS, Benson L, Rensel M, Krupp L, Waldman AT, Weinstock-Guttman B, Lotze T, Greenberg B, Aaen G, Mar S, Schreiner T, Hart J, Simpson-Yap S, Mesaros C, Barcellos LF, Waubant E. PMID: 36725329; PMCID: PMC10272045.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    68. Cross-Trait Mendelian Randomization Study to Investigate Whether Migraine Is a Risk Factor for Multiple Sclerosis. Neurology. 2023 03 28; 100(13):e1353-e1362. Horton MK, Robinson SC, Shao X, Quach H, Quach D, Choudhary V, Bellesis KH, Dorin P, Mei J, Chinn T, Meyers TJ, Bakshi N, Marcus JF, Waubant E, Schaefer CA, Barcellos LF. PMID: 36631270; PMCID: PMC10065202.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    69. Stroke Outcomes and Hyperacute Treatment Utilization in Multiple Sclerosis. Mult Scler Relat Disord. 2023 Jan; 69:104444. Schoeps VA, Waubant E, Singh N. PMID: 36493560.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    70. Therapeutic Response in Pediatric Neuromyelitis Optica Spectrum Disorder. Neurology. 2023 02 28; 100(9):e985-e994. Pizzolato Umeton R, Waltz M, Aaen GS, Benson L, Gorman M, Goyal M, Graves JS, Harris Y, Krupp L, Lotze TE, Shukla NM, Mar S, Ness J, Rensel M, Schreiner T, Tillema JM, Roalstad S, Rodriguez M, Rose J, Waubant E, Weinstock-Guttman B, Casper C, Chitnis T, US Network of Pediatric MS Centers. PMID: 36460473; PMCID: PMC9990442.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    71. Using an animal model to predict the effective human dose for oral multiple sclerosis drugs. Clin Transl Sci. 2023 03; 16(3):467-477. Liu W, Yu Z, Wang Z, Waubant EL, Zhai S, Benet LZ. PMID: 36419359; PMCID: PMC10014696.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    72. MRI lesions can often precede trigeminal neuralgia symptoms by years in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2023 03; 94(3):189-192. Dilwali S, Mark I, Waubant E. PMID: 36396446.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    73. MOG and AQP4 Antibodies among Children with Multiple Sclerosis and Controls. Ann Neurol. 2023 02; 93(2):271-284. Gaudioso CM, Mar S, Casper TC, Codden R, Nguyen A, Aaen G, Benson L, Chitnis T, Francisco C, Gorman MP, Goyal MS, Graves J, Greenberg BM, Hart J, Krupp L, Lotze T, Narula S, Pittock SJ, Rensel M, Rodriguez M, Rose J, Schreiner T, Tillema JM, Waldman A, Weinstock-Guttman B, Wheeler Y, Waubant E, Flanagan EP, United States Network of Pediatric Multiple Sclerosis Centers. PMID: 36088544; PMCID: PMC10576841.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    74. A new look at cognitive functioning in pediatric MS. Mult Scler. 2023 01; 29(1):140-149. Krupp LB, Waubant E, Waltz M, Casper TC, Belman A, Wheeler Y, Ness J, Graves J, Gorman M, Benson L, Mar S, Goyal M, Schreiner T, Weinstock-Guttman B, Rodriguez M, Tillema JM, Lotze T, Aaen G, Rensel M, Rose J, Chitinis T, George A, Charvet LE, US Network of Pediatric MS Centers. PMID: 36189711.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    75. N-Acetyl Cysteine as a Neuroprotective Agent in Progressive Multiple Sclerosis (NACPMS) trial: Study protocol for a randomized, double-blind, placebo-controlled add-on phase 2 trial. Contemp Clin Trials. 2022 11; 122:106941. Schoeps VA, Graves JS, Stern WA, Zhang L, Nourbakhsh B, Mowry EM, Henry RG, Waubant E. PMID: 36182028.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    76. The metabolic potential of the paediatric-onset multiple sclerosis gut microbiome. Mult Scler Relat Disord. 2022 Jul; 63:103829. Mirza AI, Zhu F, Knox N, Forbes JD, Bonner C, Van Domselaar G, Bernstein CN, Graham M, Marrie RA, Hart J, Yeh EA, Arnold DL, Bar-Or A, O'Mahony J, Zhao Y, Hsiao W, Banwell B, Waubant E, Tremlett H. PMID: 35500534.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    77. Reply to "Spinal Cord Atrophy Is a Preclinical Marker of Progressive MS". Ann Neurol. 2022 05; 91(5):735-736. Bischof A, Papinutto N, Keshavan A, Rajesh A, Kirkish G, Zhang X, Mallott JM, Asteggiano C, Sacco S, Gundel TJ, Zhao C, Stern WA, Caverzasi E, Zhou Y, Gomez R, Ragan NR, Santaniello A, Zhu AH, Juwono J, Bevan CJ, Bove RM, Crabtree-Hartman E, Gelfand JM, Goodin DS, Graves JS, Green AJ, Oksenberg JR, Waubant E, Wilson MR, Zamvil SS, University of California, San Francisco MS-EPIC Team, Cree BA, Hauser SL, Henry RG. PMID: 35233827; PMCID: PMC9511767.
      View in: PubMed   Mentions:    Fields:    
    78. Stability of the gut microbiota in persons with paediatric-onset multiple sclerosis and related demyelinating diseases. Mult Scler. 2022 10; 28(11):1819-1824. Liang G, Zhu F, Mirza AI, Bar-Or A, Bernstein CN, Bonner C, Forbes JD, Graham M, Hart J, Knox NC, Marrie RA, O'Mahony J, Van Domselaar G, Yeh EA, Zhao Y, Banwell B, Waubant E, Tremlett H, Canadian Paediatric Demyelinating Disease Network. PMID: 35296164; PMCID: PMC9442770.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    79. Preventing Multiple Sclerosis: The Pediatric Perspective. Front Neurol. 2022; 13:802380. Hardy D, Chitnis T, Waubant E, Banwell B. PMID: 35280298; PMCID: PMC8913516.
      View in: PubMed   Mentions: 7  
    80. Effect of fingolimod on health-related quality of life in paediatric patients with multiple sclerosis: results from the phase 3 PARADIGMS Study. BMJ Neurol Open. 2022; 4(1):e000215. Krupp L, Banwell B, Chitnis T, Deiva K, Gaertner J, Ghezzi A, Huppke P, Waubant E, DeLasHeras V, Azmon A, Karan R. PMID: 35308898; PMCID: PMC8883212.
      View in: PubMed   Mentions: 7  
    81. Gene-environment interactions increase the risk of pediatric-onset multiple sclerosis associated with ozone pollution. Mult Scler. 2022 08; 28(9):1330-1339. Ziaei A, Lavery AM, Shao XM, Adams C, Casper TC, Rose J, Candee M, Weinstock-Guttman B, Aaen G, Harris Y, Graves J, Benson L, Gorman M, Rensel M, Mar S, Lotze T, Greenberg B, Chitnis T, Hart J, Waldman AT, Barcellos LF, Waubant E. PMID: 35000467; PMCID: PMC9256753.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    82. Spinal Cord Atrophy Predicts Progressive Disease in Relapsing Multiple Sclerosis. Ann Neurol. 2022 02; 91(2):268-281. Bischof A, Papinutto N, Keshavan A, Rajesh A, Kirkish G, Zhang X, Mallott JM, Asteggiano C, Sacco S, Gundel TJ, Zhao C, Stern WA, Caverzasi E, Zhou Y, Gomez R, Ragan NR, Santaniello A, Zhu AH, Juwono J, Bevan CJ, Bove RM, Crabtree E, Gelfand JM, Goodin DS, Graves JS, Green AJ, Oksenberg JR, Waubant E, Wilson MR, Zamvil SS, University of California, San Francisco MS-EPIC Team, Cree BAC, Hauser SL, Henry RG. PMID: 34878197; PMCID: PMC8916838.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    83. Metagenomic Analysis of the Pediatric-Onset Multiple Sclerosis Gut Microbiome. Neurology. 2022 03 08; 98(10):e1050-e1063. Mirza AI, Zhu F, Knox N, Forbes JD, Van Domselaar G, Bernstein CN, Graham M, Marrie RA, Hart J, Yeh EA, Arnold DL, Bar-Or A, O'Mahony J, Zhao Y, Hsiao W, Banwell B, Waubant E, Tremlett H. PMID: 34937787; PMCID: PMC8967388.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    84. The gut microbiota in pediatric multiple sclerosis and demyelinating syndromes. Ann Clin Transl Neurol. 2021 12; 8(12):2252-2269. Tremlett H, Zhu F, Arnold D, Bar-Or A, Bernstein CN, Bonner C, Forbes JD, Graham M, Hart J, Knox NC, Marrie RA, Mirza AI, O'Mahony J, Van Domselaar G, Yeh EA, Zhao Y, Banwell B, Waubant E, US Network of Pediatric MS Centers, the Canadian Pediatric Demyelinating Disease Network. PMID: 34889081; PMCID: PMC8670321.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    85. Association Between Time Spent Outdoors and Risk of Multiple Sclerosis. Neurology. 2022 01 18; 98(3):e267-e278. Sebastian P, Cherbuin N, Barcellos LF, Roalstad S, Casper C, Hart J, Aaen GS, Krupp L, Benson L, Gorman M, Candee M, Chitnis T, Goyal M, Greenberg B, Mar S, Rodriguez M, Rubin J, Schreiner T, Waldman A, Weinstock-Guttman B, Graves J, Waubant E, Lucas R, US Network of Pediatric Multiple Sclerosis Centers. PMID: 34880094; PMCID: PMC8792813.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    86. Etiological research in pediatric multiple sclerosis: A tool to assess environmental exposures (PEDiatric Italian Genetic and enviRonment ExposurE Questionnaire). Mult Scler J Exp Transl Clin. 2021 Oct; 7(4):20552173211059048. Pilotto S, Gencarelli J, Bova S, Gerosa L, Baroncini D, Olivotto S, Alfei E, Zaffaroni M, Suppiej A, Cocco E, Trojano M, Amato MP, D'Alfonso S, Martinelli-Boneschi F, Waubant E, Ghezzi A, Bergamaschi R, Pugliatti M. PMID: 34868629; PMCID: PMC8640303.
      View in: PubMed   Mentions: 3  
    87. Paediatric multiple sclerosis: a lesson from TERIKIDS. Lancet Neurol. 2021 12; 20(12):971-973. Sormani MP, Waubant E. PMID: 34800403.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    88. Interocular Difference in Retinal Nerve Fiber Layer Thickness Predicts Optic Neuritis in Pediatric-Onset Multiple Sclerosis. J Neuroophthalmol. 2021 12 01; 41(4):469-475. Waldman AT, Benson L, Sollee JR, Lavery AM, Liu GW, Green AJ, Waubant E, Heidary G, Conger D, Graves J, Greenberg B. PMID: 33105412; PMCID: PMC8846428.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    89. Multi-omic evaluation of metabolic alterations in multiple sclerosis identifies shifts in aromatic amino acid metabolism. Cell Rep Med. 2021 10 19; 2(10):100424. Fitzgerald KC, Smith MD, Kim S, Sotirchos ES, Kornberg MD, Douglas M, Nourbakhsh B, Graves J, Rattan R, Poisson L, Cerghet M, Mowry EM, Waubant E, Giri S, Calabresi PA, Bhargava P. PMID: 34755135; PMCID: PMC8561319.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansCells
    90. Family Perspectives on Clinical Research for Pediatric Multiple Sclerosis: Enhancing Equity. J Patient Exp. 2021; 8:23743735211039319. Mandel LA, O'Donnell E, Canenguez K, Castro-Mendoza PB, Lotze T, Waubant E, Weinstock-Guttmann B, Chitnis T. PMID: 34541304; PMCID: PMC8447100.
      View in: PubMed   Mentions:
    91. High titers of myelin oligodendrocyte glycoprotein antibody are only observed close to clinical events in pediatrics. Mult Scler Relat Disord. 2021 Nov; 56:103253. Lui A, Chong J, Flanagan E, Abrams AW, Krysko KM, Arikan B, Francisco C, Rutatangwa A, Waubant E, Ziaei A. PMID: 34517190; PMCID: PMC8678350.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    92. Increased Prevalence of Familial Autoimmune Disease in Children With Opsoclonus-Myoclonus Syndrome. Neurol Neuroimmunol Neuroinflamm. 2021 11; 8(6). Santoro JD, Kerr LM, Codden R, Casper TC, Greenberg BM, Waubant E, Kong SW, Mandl KD, Gorman MP. PMID: 34475249; PMCID: PMC8422990.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    93. Myelin-oligodendrocyte glycoprotein antibody-associated disease. Lancet Neurol. 2021 09; 20(9):762-772. Marignier R, Hacohen Y, Cobo-Calvo A, Pröbstel AK, Aktas O, Alexopoulos H, Amato MP, Asgari N, Banwell B, Bennett J, Brilot F, Capobianco M, Chitnis T, Ciccarelli O, Deiva K, De Sèze J, Fujihara K, Jacob A, Kim HJ, Kleiter I, Lassmann H, Leite MI, Linington C, Meinl E, Palace J, Paul F, Petzold A, Pittock S, Reindl M, Sato DK, Selmaj K, Siva A, Stankoff B, Tintore M, Traboulsee A, Waters P, Waubant E, Weinshenker B, Derfuss T, Vukusic S, Hemmer B. PMID: 34418402.
      View in: PubMed   Mentions: 229     Fields:    Translation:Humans
    94. Gut microbiome is associated with multiple sclerosis activity in children. Ann Clin Transl Neurol. 2021 09; 8(9):1867-1883. Horton MK, McCauley K, Fadrosh D, Fujimura K, Graves J, Ness J, Wheeler Y, Gorman MP, Benson LA, Weinstock-Guttman B, Waldman A, Rodriguez M, Tillema JM, Krupp L, Belman A, Mar S, Rensel M, Chitnis T, Casper TC, Rose J, Hart J, Shao X, Tremlett H, Lynch SV, Barcellos LF, Waubant E, U.S. Network of Pediatric MS Centers. PMID: 34409759; PMCID: PMC8419410.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    95. Familial History of Autoimmune Disorders Among Patients With Pediatric Multiple Sclerosis. Neurol Neuroimmunol Neuroinflamm. 2021 09; 8(5). Greenberg BM, Casper TC, Mar SS, Ness JM, Plumb P, Liang S, Goyal M, Weinstock-Guttman B, Rodriguez M, Aaen GS, Belman A, Barcellos LF, Rose JW, Gorman MP, Benson LA, Candee M, Chitnis T, Harris YC, Kahn IL, Roalstad S, Hart J, Lotze TE, Rensel M, Rubin JP, Schreiner TL, Tillema JM, Waldman AT, Krupp L, Graves J, Drake K, Waubant E. PMID: 34353894; PMCID: PMC8362349.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    96. Ethical considerations in the treatment of multiple sclerosis fatigue. Mult Scler Relat Disord. 2021 Sep; 54:103129. Nourbakhsh B, Waubant E, Evers AWM, Solomon AJ. PMID: 34247106.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    97. Incidence of Acute Disseminated Encephalomyelitis in China: First National Survey. Neurosci Bull. 2021 Jun; 37(6):761-762. Waubant E. PMID: 34033060; PMCID: PMC8192619.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    98. Multiple Sclerosis Is Rare in Epstein-Barr Virus-Seronegative Children with Central Nervous System Inflammatory Demyelination. Ann Neurol. 2021 06; 89(6):1234-1239. Nourbakhsh B, Cordano C, Asteggiano C, Ruprecht K, Otto C, Rutatangwa A, Lui A, Hart J, Flanagan EP, James JA, Waubant E. PMID: 33704815; PMCID: PMC8244760.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    99. A pilot study of oxidative pathways in MS fatigue: randomized trial of N-acetyl cysteine. Ann Clin Transl Neurol. 2021 04; 8(4):811-824. Krysko KM, Bischof A, Nourbakhsh B, Henry RG, Revirajan N, Manguinao M, Nguyen K, Akula A, Li Y, Waubant E. PMID: 33675156; PMCID: PMC8045913.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    100. Safety evaluation of shorter infusion for ocrelizumab in a substudy of the Phase IIIb CHORDS trial. Ann Clin Transl Neurol. 2021 03; 8(3):711-715. Bermel RA, Waubant E, Pardo G, Bass A, Repovic P, Newsome S, Lindsey JW, Kile D, Pradhan A, Musch B, Zabeti A. PMID: 33621404; PMCID: PMC7951110.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    101. Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial. Lancet Neurol. 2021 01; 20(1):38-48. Nourbakhsh B, Revirajan N, Morris B, Cordano C, Creasman J, Manguinao M, Krysko K, Rutatangwa A, Auvray C, Aljarallah S, Jin C, Mowry E, McCulloch C, Waubant E. PMID: 33242419; PMCID: PMC7772747.
      View in: PubMed   Mentions: 70     Fields:    Translation:Humans
    102. Biosensor vital sign detects multiple sclerosis progression. Ann Clin Transl Neurol. 2021 01; 8(1):4-14. Krysko KM, Akhbardeh A, Arjona J, Nourbakhsh B, Waubant E, Antoine Gourraud P, Graves JS. PMID: 33211403; PMCID: PMC7818086.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    103. Neurite Orientation Dispersion and Density Imaging for Assessing Acute Inflammation and Lesion Evolution in MS. AJNR Am J Neuroradiol. 2020 12; 41(12):2219-2226. Sacco S, Caverzasi E, Papinutto N, Cordano C, Bischof A, Gundel T, Cheng S, Asteggiano C, Kirkish G, Mallott J, Stern WA, Bastianello S, Bove RM, Gelfand JM, Goodin DS, Green AJ, Waubant E, Wilson MR, Zamvil SS, Cree BA, Hauser SL, Henry RG, University of California, San Francisco MS-EPIC Team. PMID: 33154077; PMCID: PMC7963254.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    104. Improved relapse recovery in paediatric compared to adult multiple sclerosis. Brain. 2020 09 01; 143(9):2733-2741. Chitnis T, Aaen G, Belman A, Benson L, Gorman M, Goyal MS, Graves JS, Harris Y, Krupp L, Lotze T, Mar S, Ness J, Rensel M, Schreiner T, Tillema JM, Waubant E, Weinstock-Guttman B, Roalstad S, Rose J, Weiner HL, Casper TC, Rodriguez M, US Network of Paediatric Multiple Sclerosis Centers. PMID: 32810215.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    105. Pediatric Multiple Sclerosis Severity Score in a large US cohort. Neurology. 2020 09 29; 95(13):e1844-e1853. Santoro JD, Waltz M, Aaen G, Belman A, Benson L, Gorman M, Goyal MS, Graves JS, Harris Y, Krupp L, Lotze T, Mar S, Moodley M, Ness J, Rensel M, Rodriguez M, Schreiner T, Tillema JM, Waubant E, Weinstock-Guttman B, Hurtubise BF, Roalstad S, Rose J, Casper TC, Chitnis T, US Network of Pediatric MS Centers. PMID: 32690790; PMCID: PMC7682820.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    106. Ocrelizumab exposure in the second trimester of pregnancy without neonatal B-cell depletion. Mult Scler Relat Disord. 2020 Oct; 45:102398. Rolfes M, Rutatangwa A, Waubant E, Krysko KM. PMID: 32707531.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    107. A validation study for remote testing of cognitive function in multiple sclerosis. Mult Scler. 2021 04; 27(5):795-798. Barcellos LF, Horton M, Shao X, Bellesis KH, Chinn T, Waubant E, Bakshi N, Marcus J, Benedict RH, Schaefer C. PMID: 32662747; PMCID: PMC7854963.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    108. Two-armed active comparator trials are unethical in paediatric multiple sclerosis - Commentary. Mult Scler. 2020 10; 26(12):1474-1475. Waubant E. PMID: 32648815.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    109. Temporal profile of lymphocyte counts and relationship with infections with fingolimod therapy in paediatric patients with multiple sclerosis: Results from the PARADIGMS study. Mult Scler. 2021 05; 27(6):922-932. Chitnis T, Banwell B, Krupp L, Arnold DL, Bar-Or A, Brück W, Giovannoni G, Greenberg B, Ghezzi A, Waubant E, Rostasy K, Deiva K, Huppke P, Wolinsky JS, Zhang Y, Azmon A, K-Laflamme A, Karan R, Gärtner J. PMID: 32633694.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    110. Bile acid metabolism is altered in multiple sclerosis and supplementation ameliorates neuroinflammation. J Clin Invest. 2020 07 01; 130(7):3467-3482. Bhargava P, Smith MD, Mische L, Harrington E, Fitzgerald KC, Martin K, Kim S, Reyes AA, Gonzalez-Cardona J, Volsko C, Tripathi A, Singh S, Varanasi K, Lord HN, Meyers K, Taylor M, Gharagozloo M, Sotirchos ES, Nourbakhsh B, Dutta R, Mowry EM, Waubant E, Calabresi PA. PMID: 32182223; PMCID: PMC7324171.
      View in: PubMed   Mentions: 123     Fields:    Translation:HumansAnimalsCells
    111. Dare we mention the C-word? Mult Scler Relat Disord. 2020 Aug; 43:102340. Giovannoni G, Hawkes CH, Lechner-Scott J, Levy M, Waubant E. PMID: 32660744.
      View in: PubMed   Mentions:    Fields:    
    112. Rituximab in patients with pediatric multiple sclerosis and other demyelinating disorders of the CNS: Practical considerations. Mult Scler. 2021 10; 27(12):1814-1822. Ghezzi A, Banwell B, Bar-Or A, Chitnis T, Dale RC, Gorman M, Kornek B, Krupp L, Krysko KM, Nosadini M, Rostasy K, Salzer J, Schreiner T, Tenembaum S, Waubant E. PMID: 32552353.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    113. Do you believe in Gad? Mult Scler Relat Disord. 2020 Sep; 44:102299. Maghzi AH, Sicotte NL, Waubant E. PMID: 32593143.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    114. Changes in patient and physician attitudes resulting from COVID-19 in neuromyelitis optica spectrum disorder and multiple sclerosis. Mult Scler Relat Disord. 2020 07; 42:102259. Salama S, Giovannoni G, Hawkes CH, Lechner-Scott J, Waubant E, Levy M. PMID: 32571580; PMCID: PMC7267795.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsPHPublic Health
    115. Autoimmune Encephalitis in Children: A Case Series at a Tertiary Care Center. J Child Neurol. 2020 08; 35(9):591-599. Rutatangwa A, Mittal N, Francisco C, Nash K, Waubant E. PMID: 32458722.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    116. Real-World Effectiveness of Initial Disease-Modifying Therapies in Pediatric Multiple Sclerosis. Ann Neurol. 2020 07; 88(1):42-55. Krysko KM, Graves JS, Rensel M, Weinstock-Guttman B, Rutatangwa A, Aaen G, Belman A, Benson L, Chitnis T, Gorman M, Goyal MS, Harris Y, Krupp L, Lotze T, Mar S, Moodley M, Ness J, Rodriguez M, Rose J, Schreiner T, Tillema JM, Waltz M, Casper TC, Waubant E, US Network of Pediatric MS Centers. PMID: 32267005.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    117. Is multiple sclerosis a risk factor for infections? Mult Scler Relat Disord. 2020 Jun; 41:102184. Lechner-Scott J, Waubant E, Levy M, Hawkes C, Giovannoni G. PMID: 32571610; PMCID: PMC7204651.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    118. The future of microbiome research in neuroinflammatory disorders. Mult Scler Relat Disord. 2020 May; 40:102098. Waubant E, Pröbstel AK, Levy M, Hawkes CH, Giovannoni G, Lechner-Scott J, Tremlett H. PMID: 32312515.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    119. The COVID-19 pandemic and the use of MS disease-modifying therapies. Mult Scler Relat Disord. 2020 04; 39:102073. Giovannoni G, Hawkes C, Lechner-Scott J, Levy M, Waubant E, Gold J. PMID: 32334820; PMCID: PMC7138156.
      View in: PubMed   Mentions: 118     Fields:    Translation:HumansCellsPHPublic Health
    120. Big pharma and social responsibility. Mult Scler Relat Disord. 2020 Apr; 39:102069. Hawkes CH, Giovannoni G, Levy M, Lechner-Scott J, Waubant E. PMID: 32334821.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    121. Effect of fingolimod on MRI outcomes in patients with paediatric-onset multiple sclerosis: results from the phase 3 PARADIGMS study. J Neurol Neurosurg Psychiatry. 2020 05; 91(5):483-492. Arnold DL, Banwell B, Bar-Or A, Ghezzi A, Greenberg BM, Waubant E, Giovannoni G, Wolinsky JS, Gärtner J, Rostásy K, Krupp L, Tardieu M, Brück W, Stites TE, Pearce GL, Häring DA, Merschhemke M, Chitnis T, PARADIGMS Study Investigators. PMID: 32132224; PMCID: PMC7231437.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    122. Association Between Breastfeeding and Postpartum Multiple Sclerosis Relapses: A Systematic Review and Meta-analysis. JAMA Neurol. 2020 03 01; 77(3):327-338. Krysko KM, Rutatangwa A, Graves J, Lazar A, Waubant E. PMID: 31816024; PMCID: PMC6902174.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    123. Ageing and multiple sclerosis. Mult Scler Relat Disord. 2020 02; 38:101953. Giovannoni G, Hawkes CH, Lechner-Scott J, Levy M, Waubant E. PMID: 32164909.
      View in: PubMed   Mentions: 2     Fields:    
    124. "Is this new medicine going to help me walk again?" Mult Scler Relat Disord. 2020 01; 37:101875. Levy M, Waubant E, Hawkes C, Giovannoni G, Lechner-Scott J. PMID: 32172990.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    125. Cognitive processing speed in pediatric-onset multiple sclerosis: Baseline characteristics of impairment and prediction of decline. Mult Scler. 2020 12; 26(14):1938-1947. Wallach AI, Waltz M, Casper TC, Aaen G, Belman A, Benson L, Chitnis T, Gorman M, Graves J, Harris Y, Lotze TE, Mar S, Moodley M, Ness JM, Rensel M, Rodriguez M, Rose JW, Schreiner T, Tillema JM, Waubant E, Weinstock-Guttman B, Charvet LE, Krupp LB. PMID: 31775571.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    126. Silent symptoms of multiple sclerosis. Mult Scler Relat Disord. 2019 11; 36:101453. Lechner-Scott J, Waubant E, Levy M, Hawkes C. PMID: 31812240.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    127. The multiple sclerosis gut microbiota: A systematic review. Mult Scler Relat Disord. 2020 Jan; 37:101427. Mirza A, Forbes JD, Zhu F, Bernstein CN, Van Domselaar G, Graham M, Waubant E, Tremlett H. PMID: 32172998.
      View in: PubMed   Mentions: 85     Fields:    Translation:Humans
    128. Grassroot efforts towards diversity in MS care and research: Win-win for patients and science. Mult Scler Relat Disord. 2019 10; 35:A1-A2. Waubant E, Levy M, Lechner-Scott J, Giovannoni G, Hawkes C. PMID: 31679745.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    129. Clinical Features and Outcomes of Pediatric Monophasic and Recurrent Idiopathic Optic Neuritis. J Child Neurol. 2020 01; 35(1):77-83. Jonzzon S, Suleiman L, Yousef A, Young B, Hart J, Peschl P, Reindl M, Schaller KL, Bennett JL, Waubant E, Graves JS. PMID: 31566057; PMCID: PMC7018758.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    130. Seafood, fatty acid biosynthesis genes, and multiple sclerosis susceptibility. Mult Scler. 2020 10; 26(12):1476-1485. Langer-Gould A, Black LJ, Waubant E, Smith JB, Wu J, Gonzales EG, Shao X, Koebnick C, Lucas RM, Xiang A, Barcellos LF. PMID: 33063621; PMCID: PMC7573200.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    131. Consistent control of disease activity with fingolimod versus IFN β-1a in paediatric-onset multiple sclerosis: further insights from PARADIGMS. J Neurol Neurosurg Psychiatry. 2020 01; 91(1):58-66. Deiva K, Huppke P, Banwell B, Chitnis T, Gärtner J, Krupp L, Waubant E, Stites T, Pearce GL, Merschhemke M. PMID: 31467033; PMCID: PMC6952840.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    132. Environmental and genetic risk factors for MS: an integrated review. Ann Clin Transl Neurol. 2019 09; 6(9):1905-1922. Waubant E, Lucas R, Mowry E, Graves J, Olsson T, Alfredsson L, Langer-Gould A. PMID: 31392849; PMCID: PMC6764632.
      View in: PubMed   Mentions: 157     Fields:    Translation:HumansPHPublic Health
    133. Multiple sclerosis and migration revisited. Mult Scler Relat Disord. 2019 09; 34:A1-A2. Hawkes CH, Giovannoni G, Lechner-Scott J, Levy M, Waubant E. PMID: 31543261.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    134. Implementing the 2017 McDonald criteria for the diagnosis of multiple sclerosis. Nat Rev Neurol. 2019 08; 15(8):441-445. Zipp F, Oh J, Fragoso YD, Waubant E. PMID: 31086264.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    135. A retrospective cohort study of plasma exchange in central nervous system demyelinating events in children. Mult Scler Relat Disord. 2019 Oct; 35:50-54. Manguinao M, Krysko KM, Maddike S, Rutatangwa A, Francisco C, Hart J, Chong J, Graves JS, Waubant E. PMID: 31319355.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    136. Editorial on: Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder. Mult Scler Relat Disord. 2019 08; 33:A1-A2. Pardo S, Giovannoni G, Hawkes C, Lechner-Scott J, Waubant E, Levy M. PMID: 31324299.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    137. Introducing the International Women in Multiple Sclerosis network. Lancet Neurol. 2019 06; 18(6):521. Jokubaitis VG, Pröbstel AK, Arrambide G, Costello F, Waubant E. PMID: 31122489.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    138. miRNA contributions to pediatric-onset multiple sclerosis inferred from GWAS. Ann Clin Transl Neurol. 2019 Jun; 6(6):1053-1061. Rhead B, Shao X, Graves JS, Chitnis T, Waldman AT, Lotze T, Schreiner T, Belman A, Krupp L, Greenberg BM, Weinstock-Guttman B, Aaen G, Tillema JM, Rodriguez M, Hart J, Caillier S, Ness J, Harris Y, Rubin J, Candee MS, Gorman M, Benson L, Mar S, Kahn I, Rose J, Casper TC, Quach H, Quach D, Schaefer C, Waubant E, Barcellos LF, US Network of Pediatric MS Centers. PMID: 31211169; PMCID: PMC6562070.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    139. Vitamin D genes influence MS relapses in children. Mult Scler. 2020 07; 26(8):894-901. Graves JS, Barcellos LF, Krupp L, Belman A, Shao X, Quach H, Hart J, Chitnis T, Weinstock-Guttman B, Aaen G, Benson L, Gorman M, Greenberg B, Lotze T, Soe M, Ness J, Rodriguez M, Rose J, Schreiner T, Tillema JM, Waldman A, Casper TC, Waubant E. PMID: 31081484; PMCID: PMC6851448.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    140. Three suggestions to decrease the financial burden of MS treatments. Mult Scler Relat Disord. 2019 May; 30:A1. Waubant E, Giovannoni G, Hawkes C, Lechner-Scott J, Levy M. PMID: 30987755.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    141. Clinical trials of disease-modifying agents in pediatric MS: Opportunities, challenges, and recommendations from the IPMSSG. Neurology. 2019 05 28; 92(22):e2538-e2549. Waubant E, Banwell B, Wassmer E, Sormani MP, Amato MP, Hintzen R, Krupp L, Rostásy K, Tenembaum S, Chitnis T, IPMSSG. PMID: 31043474; PMCID: PMC6556085.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    142. One size doesn't fit all. Mult Scler Relat Disord. 2019 06; 31:A1-A2. Lechner-Scott J, Giovannoni G, Hawkes C, Levy M, Waubant E. PMID: 31159999.
      View in: PubMed   Mentions:    Fields:    
    143. Acute flaccid myelitis in the 21st century: reminiscence of poliomyelitis or a new emergent disease. Mult Scler Relat Disord. 2019 Apr; 29:A1-A2. Levy M, Giovannoni G, Hawkes C, Lechner-Scott J, Waubant E. PMID: 30885376.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    144. Mind the gap: Quantifying gender representation as a first step to solve the problem? Neurology. 2019 04 09; 92(15):698-699. Waubant E, Gilmore W. PMID: 30894445.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    145. Multiple Sclerosis and Vitamin D - Caviar or a Dog's Dinner? Mult Scler Relat Disord. 2019 Feb; 28:A1-A2. Hawkes C, Giovannoni G, Lechner-Scott J, Levy M, Waubant E. PMID: 30823982.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    146. Admixture mapping reveals evidence of differential multiple sclerosis risk by genetic ancestry. PLoS Genet. 2019 01; 15(1):e1007808. Chi C, Shao X, Rhead B, Gonzales E, Smith JB, Xiang AH, Graves J, Waldman A, Lotze T, Schreiner T, Weinstock-Guttman B, Aaen G, Tillema JM, Ness J, Candee M, Krupp L, Gorman M, Benson L, Chitnis T, Mar S, Belman A, Casper TC, Rose J, Moodley M, Rensel M, Rodriguez M, Greenberg B, Kahn L, Rubin J, Schaefer C, Waubant E, Langer-Gould A, Barcellos LF. PMID: 30653506; PMCID: PMC6353231.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    147. Should our treatment target in MS include the intrathecal plasma cell response? Mult Scler Relat Disord. 2019 01; 27:A1-A2. Giovannoni G, Hawkes C, Levy M, Lechner-Scott J, Waubant E. PMID: 30642567.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    148. Acquisition of Early Developmental Milestones and Need for Special Education Services in Pediatric Multiple Sclerosis. J Child Neurol. 2019 03; 34(3):148-152. Aaen G, Waltz M, Vargas W, Makhani N, Ness J, Harris Y, Casper TC, Benson L, Candee M, Chitnis T, Gorman M, Graves J, Greenberg B, Lotze T, Mar S, Tillema JM, Rensel M, Rodriguez M, Rose J, Rubin J, Schreiner T, Waldman A, Weinstock-Guttman B, Belman A, Waubant E, Krupp L. PMID: 30556452; PMCID: PMC6579723.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    149. Pediatric glial fibrillary acidic protein meningoencephalomyelitis: A case report and review of the literature. Mult Scler Relat Disord. 2019 Apr; 29:148-152. Francisco C, Meddles K, Waubant E. PMID: 30885369.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    150. Subclinical Saccadic Eye Movement Dysfunction in Pediatric Multiple Sclerosis. J Child Neurol. 2019 01; 34(1):38-43. Yousef A, Devereux M, Gourraud PA, Jonzzon S, Suleiman L, Waubant E, Green A, Graves JS. PMID: 30463467.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    151. Body mass index, but not vitamin D status, is associated with brain volume change in MS. Neurology. 2018 12 11; 91(24):e2256-e2264. Mowry EM, Azevedo CJ, McCulloch CE, Okuda DT, Lincoln RR, Waubant E, Hauser SL, Pelletier D. PMID: 30429274; PMCID: PMC6329329.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    152. Vaccines and disease-modifying treatments. Mult Scler Relat Disord. 2018 11; 26:A1-A2. Waubant E, Giovannoni G, Hawkes C, Levy M. PMID: 30573174.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    153. Puberty onset and pediatric multiple sclerosis activity in boys. Mult Scler Relat Disord. 2019 Jan; 27:184-187. Young B, Waubant E, Lulu S, Graves J. PMID: 30390578.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    154. Use of newer disease-modifying therapies in pediatric multiple sclerosis in the US. Neurology. 2018 11 06; 91(19):e1778-e1787. Krysko KM, Graves J, Rensel M, Weinstock-Guttman B, Aaen G, Benson L, Chitnis T, Gorman M, Goyal M, Krupp L, Lotze T, Mar S, Rodriguez M, Rose J, Waltz M, Charles Casper T, Waubant E, US Network of Pediatric MS Centers. PMID: 30333163; PMCID: PMC6251604.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    155. Several household chemical exposures are associated with pediatric-onset multiple sclerosis. Ann Clin Transl Neurol. 2018 Dec; 5(12):1513-1521. Mar S, Liang S, Waltz M, Casper TC, Goyal M, Greenberg B, Weinstock-Guttman B, Rodriguez M, Aaen G, Belman A, Barcellos LF, Rose J, Gorman M, Benson L, Candee M, Chitnis T, Harris Y, Kahn I, Roalsted S, Hart J, Lotze T, Moodley M, Ness J, Rensel M, Rubin J, Schreiner T, Tillema JM, Waldman A, Krupp L, Graves JS, Waubant E, U.S. Network of Pediatric Multiple Sclerosis Centers. PMID: 30564618; PMCID: PMC6292189.
      View in: PubMed   Mentions: 10     Fields:    
    156. Detection of HHV-6 and EBV and Cytokine Levels in Saliva From Children With Seizures: Results of a Multi-Center Cross-Sectional Study. Front Neurol. 2018; 9:834. Bartolini L, Piras E, Sullivan K, Gillen S, Bumbut A, Lin CM, Leibovitch EC, Graves JS, Waubant EL, Chamberlain JM, Gaillard WD, Jacobson S. PMID: 30344507; PMCID: PMC6182262.
      View in: PubMed   Mentions: 15  
    157. Refining the Nosology of Antigen-Specific Diseases Within the Spectrum of Neuromyelitis Optica. Mult Scler Relat Disord. 2018 10; 25:A1-A2. Levy M, Giovannoni G, Hawkes C, Waubant E. PMID: 30384960.
      View in: PubMed   Mentions: 1     Fields:    
    158. Urban air quality and associations with pediatric multiple sclerosis. Ann Clin Transl Neurol. 2018 Oct; 5(10):1146-1153. Lavery AM, Waubant E, Casper TC, Roalstad S, Candee M, Rose J, Belman A, Weinstock-Guttman B, Aaen G, Tillema JM, Rodriguez M, Ness J, Harris Y, Graves J, Krupp L, Charvet L, Benson L, Gorman M, Moodley M, Rensel M, Goyal M, Mar S, Chitnis T, Schreiner T, Lotze T, Greenberg B, Kahn I, Rubin J, Waldman AT. PMID: 30349849; PMCID: PMC6186930.
      View in: PubMed   Mentions: 22     Fields:    
    159. Altered tryptophan metabolism is associated with pediatric multiple sclerosis risk and course. Ann Clin Transl Neurol. 2018 Oct; 5(10):1211-1221. Nourbakhsh B, Bhargava P, Tremlett H, Hart J, Graves J, Waubant E. PMID: 30349856; PMCID: PMC6186945.
      View in: PubMed   Mentions: 45     Fields:    
    160. Heterogeneity in association of remote herpesvirus infections and pediatric MS. Ann Clin Transl Neurol. 2018 Oct; 5(10):1222-1228. Nourbakhsh B, Rutatangwa A, Waltz M, Rensel M, Moodley M, Graves J, Casper TC, Waldman A, Belman A, Greenberg B, Goyal M, Harris Y, Kahn I, Lotze T, Mar S, Schreiner T, Aaen G, Hart J, Ness J, Rubin J, Tillema JM, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Rose J, Candee M, Weinstock-Guttman B, Shao X, Barcellos L, James J, Waubant E, US Network of Pediatric MS Centers. PMID: 30349857; PMCID: PMC6186938.
      View in: PubMed   Mentions: 16     Fields:    
    161. Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis. N Engl J Med. 2018 09 13; 379(11):1017-1027. Chitnis T, Arnold DL, Banwell B, Brück W, Ghezzi A, Giovannoni G, Greenberg B, Krupp L, Rostásy K, Tardieu M, Waubant E, Wolinsky JS, Bar-Or A, Stites T, Chen Y, Putzki N, Merschhemke M, Gärtner J, PARADIGMS Study Group. PMID: 30207920.
      View in: PubMed   Mentions: 113     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    162. Editors' Welcome. Mult Scler Relat Disord. 2018 08; 24:A1-A2. Hawkes CH, Giovannoni G, Levy M, Waubant E. PMID: 30190056.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    163. Is cognitive impairment in multiple sclerosis reversible? Mult Scler Relat Disord. 2018 07; 23:A1. Giovannoni G, Hawkes C, Levy M, Waubant E. PMID: 30049507.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    164. Diagnosing and caring for MS in Haiti. Mult Scler Relat Disord. 2018 05; 22:A1-A2. Waubant E, Berkowitz A, Giovannoni G, Hawkes C, Levy M. PMID: 29807822.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    165. Editors' Welcome: Pregnancy and progressive multifocal leukoencephalopathy. Mult Scler Relat Disord. 2018 04; 21:A1-A2. Levy M, Giovannoni G, Hawkes C, Waubant E. PMID: 29724377.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    166. Correction to: Impact of an electronic monitoring device and behavioural feedback on adherence to multiple sclerosis therapies in youth: results of a randomized trial. Qual Life Res. 2018 04; 27(4):1117. Yeh EA, Grover SA, Powell VE, Alper G, Banwell BL, Edwards K, Gorman M, Graves J, Lotze TE, Mah JK, Mednick L, Ness J, Obadia M, Slater R, Waldman A, Waubant E, Schwartz CE, Pediatric MS Adherence Study Group. PMID: 29274015; PMCID: PMC6197804.
      View in: PubMed   Mentions:    Fields:    
    167. Early infectious exposures are not associated with increased risk of pediatric-onset multiple sclerosis. Mult Scler Relat Disord. 2018 May; 22:103-107. Suleiman L, Waubant E, Aaen G, Belman A, Benson L, Candee M, Chitnis T, Gorman M, Goyal M, Greenberg B, Harris Y, Hart J, Kahn I, Krupp L, Lotze T, Mar S, Moodley M, Ness J, Nourbakhsh B, Rensel M, Rodriguez M, Rose J, Rubin J, Schreiner T, Tillema JM, Waldman A, Weinstock-Guttman B, Casper TC, Waltz M, Graves JS, Network of Pediatric Multiple Sclerosis Centers.. PMID: 29653437; PMCID: PMC6066281.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    168. Prevalence of salivary human herpesviruses in pediatric multiple sclerosis cases and controls. Mult Scler. 2019 04; 25(5):644-652. Leibovitch EC, Lin CM, Billioux BJ, Graves J, Waubant E, Jacobson S. PMID: 29569515; PMCID: PMC6119543.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    169. Multiple sclerosis onset after granulocyte macrophage colony-stimulating factor withdrawal. Mult Scler Relat Disord. 2018 Feb; 20:178-180. Chong J, Cohen M, Waubant E. PMID: 29414294.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    170. Editors' Welcome. Mult Scler Relat Disord. 2018 02; 20:A1-A2. Hawkes C, Giovannoni G, Levy M, Waubant E. PMID: 29579630.
      View in: PubMed   Mentions:    Fields:    
    171. Are the high-costs of MS disease-modifying therapies justified? Mult Scler Relat Disord. 2018 02; 20:A3-A5. Giovannoni G, Hawkes C, Levy M, Waubant E. PMID: 29579631.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    172. Editors' Welcome. Mult Scler Relat Disord. 2018 01; 19:A1-A2. Giovannoni G, Hawkes C, Levy M, Lublin F, Waubant E. PMID: 29409600.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    173. The Gut Microbiota and Pediatric Multiple Sclerosis: Recent Findings. Neurotherapeutics. 2018 01; 15(1):102-108. Tremlett H, Waubant E. PMID: 28940049; PMCID: PMC5794692.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    174. Gut microbiome and pediatric multiple sclerosis. Mult Scler. 2018 01; 24(1):64-68. Tremlett H, Waubant E. PMID: 29307301.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    175. Effect of puberty on multiple sclerosis risk and course. Mult Scler. 2018 01; 24(1):32-35. Waubant E. PMID: 29307289.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    176. Ovarian aging is associated with gray matter volume and disability in women with MS. Neurology. 2018 01 16; 90(3):e254-e260. Graves JS, Henry RG, Cree BAC, Lambert-Messerlian G, Greenblatt RM, Waubant E, Cedars MI, Zhu A, University of California, San Francisco MS-EPIC Team, , Bacchetti P, Hauser SL, Oksenberg JR. PMID: 29273686; PMCID: PMC5772165.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    177. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018 02; 17(2):162-173. Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintoré M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA. PMID: 29275977.
      View in: PubMed   Mentions: 3501     Fields:    Translation:Humans
    178. Treatment of fatigue with methylphenidate, modafinil and amantadine in multiple sclerosis (TRIUMPHANT-MS): Study design for a pragmatic, randomized, double-blind, crossover clinical trial. Contemp Clin Trials. 2018 01; 64:67-76. Nourbakhsh B, Revirajan N, Waubant E. PMID: 29113955.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    179. Editors' Welcome. Mult Scler Relat Disord. 2017 11; 18:A1-A2. Waubant E, Giovannoni G, Hawkes C, Lublin F. PMID: 29141832.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    180. The multiple sclerosis risk allele within the AHI1 gene is associated with relapses in children and adults. Mult Scler Relat Disord. 2018 Jan; 19:161-165. Graves JS, Barcellos LF, Simpson S, Belman A, Lin R, Taylor BV, Ponsonby AL, Dwyer T, Krupp L, Waubant E, van der Mei IAF. PMID: 29409597; PMCID: PMC5806144.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    181. Contribution of dietary intake to relapse rate in early paediatric multiple sclerosis. J Neurol Neurosurg Psychiatry. 2018 01; 89(1):28-33. Azary S, Schreiner T, Graves J, Waldman A, Belman A, Guttman BW, Aaen G, Tillema JM, Mar S, Hart J, Ness J, Harris Y, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Rose J, Barcellos LF, Lotze T, Carmichael SL, Roalstad S, Casper CT, Waubant E. PMID: 28993476; PMCID: PMC5732893.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansAnimals
    182. Genetic risk factors for pediatric-onset multiple sclerosis. Mult Scler. 2018 12; 24(14):1825-1834. Gianfrancesco MA, Stridh P, Shao X, Rhead B, Graves JS, Chitnis T, Waldman A, Lotze T, Schreiner T, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema JM, Hart J, Caillier S, Ness J, Harris Y, Rubin J, Candee M, Krupp L, Gorman M, Benson L, Rodriguez M, Mar S, Kahn I, Rose J, Roalstad S, Casper TC, Shen L, Quach H, Quach D, Hillert J, Hedstrom A, Olsson T, Kockum I, Alfredsson L, Schaefer C, Barcellos LF, Waubant E, Network of Pediatric Multiple Sclerosis Centers. PMID: 28980494; PMCID: PMC5878964.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    183. Editors' Welcome. Mult Scler Relat Disord. 2017 10; 17:A1-A2. Lublin F, Giovannoni G, Hawkes C, Waubant E. PMID: 29055486.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    184. Performance of 2010 McDonald criteria and 2016 MAGNIMS guidelines in the diagnosis of primary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry. 2018 05; 89(5):550-552. Gajofatto A, Nourbakhsh B, Benedetti MD, Waubant E. PMID: 28939685.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    185. Examining the contributions of environmental quality to pediatric multiple sclerosis. Mult Scler Relat Disord. 2017 Nov; 18:164-169. Lavery AM, Waldman AT, Charles Casper T, Roalstad S, Candee M, Rose J, Belman A, Weinstock-Guttman B, Aaen G, Tillema JM, Rodriguez M, Ness J, Harris Y, Graves J, Krupp L, Benson L, Gorman M, Moodley M, Rensel M, Goyal M, Mar S, Chitnis T, Schreiner T, Lotze T, Greenberg B, Kahn I, Rubin J, Waubant E, U.S. Network of Pediatric MS Centers. PMID: 29141802; PMCID: PMC5720353.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansPHPublic Health
    186. Editors' Welcome. Mult Scler Relat Disord. 2017 08; 16:A1-A2. Hawkes C, Giovannoni G, Lublin F, Waubant E. PMID: 28755685.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    187. Genetic variation in the gene LRP2 increases relapse risk in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2017 10; 88(10):864-868. Zhou Y, Graves JS, Simpson S, Charlesworth JC, Mei IV, Waubant E, Barcellos LF, Belman A, Krupp L, Lucas R, Ponsonby AL, Taylor BV, Ausimmmune/AusLong investigators group. PMID: 28739605.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    188. Psychiatric disorders in children with demyelinating diseases of the central nervous system. Mult Scler. 2018 08; 24(9):1243-1250. Pakpoor J, Goldacre R, Schmierer K, Giovannoni G, Waubant E, Goldacre MJ. PMID: 28675955.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    189. The 'Field Hypothesis': rebound activity after stopping disease-modifying therapies. Mult Scler Relat Disord. 2017 07; 15:A1-A2. Giovannoni G, Hawkes C, Waubant E, Lublin F. PMID: 28641776.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    190. Dietary factors and pediatric multiple sclerosis: A case-control study. Mult Scler. 2018 07; 24(8):1067-1076. Pakpoor J, Seminatore B, Graves JS, Schreiner T, Waldman AT, Lotze TE, Belman A, Greenberg BM, Weinstock-Guttman B, Aaen G, Tillema JM, McDonald JC, Hart J, Ness JM, Harris Y, Rubin J, Candee M, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Mar S, Kahn I, Rose J, Carmichael SL, Roalstad S, Waltz M, Casper TC, Waubant E, US Network of Pediatric Multiple Sclerosis Centers. PMID: 28608728; PMCID: PMC5711616.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    191. Clinical Reasoning: A 16-year-old girl with subacute weakness and sensory loss. Neurology. 2017 06 06; 88(23):e225-e229. Quintanilla-Bordás C, Nourbakhsh B, Strober J, Raffel C, Waubant E. PMID: 28583938.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    192. Editors' welcome. Mult Scler Relat Disord. 2017 05; 14:A1-A2. Waubant E, Giovannoni G, Hawkes C, Lublin F. PMID: 28619438.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    193. Impact of an electronic monitoring device and behavioral feedback on adherence to multiple sclerosis therapies in youth: results of a randomized trial. Qual Life Res. 2017 09; 26(9):2333-2349. Yeh EA, Grover SA, Powell VE, Alper G, Banwell BL, Edwards K, Gorman M, Graves J, Lotze TE, Mah JK, Mednick L, Ness J, Obadia M, Slater R, Waldman A, Waubant E, Schwartz CE, Pediatric MS Adherence Study Group. PMID: 28393317; PMCID: PMC6149210.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    194. Maternal and Perinatal Exposures Are Associated With Risk for Pediatric-Onset Multiple Sclerosis. Pediatrics. 2017 Apr; 139(4). Graves JS, Chitnis T, Weinstock-Guttman B, Rubin J, Zelikovitch AS, Nourbakhsh B, Simmons T, Waltz M, Casper TC, Waubant E, Network of Pediatric Multiple Sclerosis Centers. PMID: 28562303; PMCID: PMC5369674.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansPHPublic Health
    195. Editors' Welcome. Mult Scler Relat Disord. 2017 04; 13:A1. Lublin F, Giovannoni G, Hawkes C, Waubant E. PMID: 28427712.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    196. Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MS. Neurology. 2017 Apr 25; 88(17):1623-1629. Gianfrancesco MA, Stridh P, Rhead B, Shao X, Xu E, Graves JS, Chitnis T, Waldman A, Lotze T, Schreiner T, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema JM, Hart J, Caillier S, Ness J, Harris Y, Rubin J, Candee M, Krupp L, Gorman M, Benson L, Rodriguez M, Mar S, Kahn I, Rose J, Roalstad S, Casper TC, Shen L, Quach H, Quach D, Hillert J, Bäärnhielm M, Hedstrom A, Olsson T, Kockum I, Alfredsson L, Metayer C, Schaefer C, Barcellos LF, Waubant E, Network of Pediatric Multiple Sclerosis Centers. PMID: 28356466; PMCID: PMC5405763.
      View in: PubMed   Mentions: 91     Fields:    Translation:Humans
    197. The gut microbiome in human neurological disease: A review. Ann Neurol. 2017 Mar; 81(3):369-382. Tremlett H, Bauer KC, Appel-Cresswell S, Finlay BB, Waubant E. PMID: 28220542.
      View in: PubMed   Mentions: 250     Fields:    Translation:HumansAnimals
    198. Editors' Welcome. Mult Scler Relat Disord. 2017 02; 12:A1-A2. Hawkes C, Giovannoni G, Lublin F, Waubant E. PMID: 28283115.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    199. The multiple sclerosis microbiome? Ann Transl Med. 2017 Feb; 5(3):53. Tremlett H, Waubant E. PMID: 28251132; PMCID: PMC5326653.
      View in: PubMed   Mentions: 9  
    200. Risk factors for non-adherence to disease-modifying therapy in pediatric multiple sclerosis. Mult Scler. 2018 02; 24(2):175-185. Schwartz CE, Grover SA, Powell VE, Noguera A, Mah JK, Mar S, Mednick L, Banwell BL, Alper G, Rensel M, Gorman M, Waldman A, Schreiner T, Waubant E, Yeh EA. PMID: 28273780; PMCID: PMC7370309.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    201. Serum neurofilament is associated with progression of brain atrophy and disability in early MS. Neurology. 2017 Feb 28; 88(9):826-831. Kuhle J, Nourbakhsh B, Grant D, Morant S, Barro C, Yaldizli Ö, Pelletier D, Giovannoni G, Waubant E, Gnanapavan S. PMID: 28148632; PMCID: PMC5331872.
      View in: PubMed   Mentions: 101     Fields:    Translation:Humans
    202. Editors' Welcome. Mult Scler Relat Disord. 2017 Jan; 11:A1-A2. Giovannoni G, Hawkes C, Lublin F, Waubant E. PMID: 28104262.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    203. Distinct effects of obesity and puberty on risk and age at onset of pediatric MS. Ann Clin Transl Neurol. 2016 12; 3(12):897-907. Chitnis T, Graves J, Weinstock-Guttman B, Belman A, Olsen C, Misra M, Aaen G, Benson L, Candee M, Gorman M, Greenberg B, Krupp L, Lotze T, Mar S, Ness J, Rose J, Rubin J, Schreiner T, Tillema J, Waldman A, Rodriguez M, Casper C, Waubant E, U.S. Network of Pediatric MS Centers. PMID: 28097202; PMCID: PMC5224818.
      View in: PubMed   Mentions: 37     Fields:    
    204. Rebound Syndrome in Multiple Sclerosis After Fingolimod Cessation-Reply. JAMA Neurol. 2016 11 01; 73(11):1376. Hatcher SE, Waubant E, Graves JS. PMID: 27669526.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    205. Editors' Welcome. Mult Scler Relat Disord. 2016 Nov; 10:A1. Hawkes C, Lublin F, Giovannoni G, Waubant E. PMID: 27919509.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    206. Associations between the gut microbiota and host immune markers in pediatric multiple sclerosis and controls. BMC Neurol. 2016 Sep 21; 16(1):182. Tremlett H, Fadrosh DW, Faruqi AA, Hart J, Roalstad S, Graves J, Spencer CM, Lynch SV, Zamvil SS, Waubant E, US Network of Pediatric MS Centers. PMID: 27652609; PMCID: PMC5031272.
      View in: PubMed   Mentions: 64     Fields:    
    207. Environmental and genetic factors in pediatric inflammatory demyelinating diseases. Neurology. 2016 Aug 30; 87(9 Suppl 2):S20-7. Waubant E, Ponsonby AL, Pugliatti M, Hanwell H, Mowry EM, Hintzen RQ. PMID: 27572857.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    208. International Pediatric MS Study Group Global Members Symposium report. Neurology. 2016 Aug 30; 87(9 Suppl 2):S110-6. Wassmer E, Chitnis T, Pohl D, Amato MP, Banwell B, Ghezzi A, Hintzen RQ, Krupp LB, Makhani N, Rostásy K, Tardieu M, Tenembaum S, Waldman A, Waubant E, Kornberg AJ. PMID: 27572855; PMCID: PMC10688073.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    209. Biopsy-Supported Tumefactive Demyelination of the Central Nervous System in Children. J Child Neurol. 2016 12; 31(14):1528-1533. Hanumanthe SB, Francisco C, Hart J, Graves J, Waubant E. PMID: 27572815.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    210. Clinical trials for pediatric MS should be prioritized to test only one or two of the most promising agents - NO. Mult Scler. 2016 11; 22(13):1651-1653. Francisco C, Graves J, Waubant E. PMID: 27473402.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    211. Fatigue and depression predict quality of life in patients with early multiple sclerosis: a longitudinal study. Eur J Neurol. 2016 09; 23(9):1482-6. Nourbakhsh B, Julian L, Waubant E. PMID: 27416110.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    212. Sex differences and subclinical retinal injury in pediatric-onset MS. Mult Scler. 2017 Mar; 23(3):447-455. Graves JS, Chohan H, Cedars B, Arnow S, Yiu H, Waubant E, Green A. PMID: 27306618.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    213. Characteristics of Children and Adolescents With Multiple Sclerosis. Pediatrics. 2016 07; 138(1). Belman AL, Krupp LB, Olsen CS, Rose JW, Aaen G, Benson L, Chitnis T, Gorman M, Graves J, Harris Y, Lotze T, Ness J, Rodriguez M, Tillema JM, Waubant E, Weinstock-Guttman B, Casper TC, US Network of Pediatric MS Centers. PMID: 27358474; PMCID: PMC4925083.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    214. Rebound Syndrome in Patients With Multiple Sclerosis After Cessation of Fingolimod Treatment. JAMA Neurol. 2016 07 01; 73(7):790-4. Hatcher SE, Waubant E, Nourbakhsh B, Crabtree-Hartman E, Graves JS. PMID: 27135594.
      View in: PubMed   Mentions: 87     Fields:    Translation:Humans
    215. Dietary salt intake and time to relapse in paediatric multiple sclerosis. J Neurol Neurosurg Psychiatry. 2016 12; 87(12):1350-1353. Nourbakhsh B, Graves J, Casper TC, Lulu S, Waldman A, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema JM, Hart J, Ness J, Rubin J, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Rose J, Barcellos L, Waubant E, Network of Pediatric Multiple Sclerosis Centers. PMID: 27343226; PMCID: PMC5370574.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    216. Gut microbiota in early pediatric multiple sclerosis: a case-control study. Eur J Neurol. 2016 Aug; 23(8):1308-1321. Tremlett H, Fadrosh DW, Faruqi AA, Zhu F, Hart J, Roalstad S, Graves J, Lynch S, Waubant E, US Network of Pediatric MS Centers. PMID: 27176462; PMCID: PMC4955679.
      View in: PubMed   Mentions: 187     Fields:    Translation:Humans
    217. Subcortical grey matter volumes predict subsequent walking function in early multiple sclerosis. J Neurol Sci. 2016 Jul 15; 366:229-233. Nourbakhsh B, Azevedo C, Maghzi AH, Spain R, Pelletier D, Waubant E. PMID: 27288812.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    218. Clinical Reasoning: Left hemiparesis, ataxia, and optic neuritis in a child previously treated for pineoblastoma. Neurology. 2016 04 12; 86(15):e161-e165. Vila-Bedmar S, Nourbakhsh B, Anzalone S, Waubant E. PMID: 27163667.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    219. Gut microbiota composition and relapse risk in pediatric MS: A pilot study. J Neurol Sci. 2016 Apr 15; 363:153-7. Tremlett H, Fadrosh DW, Faruqi AA, Hart J, Roalstad S, Graves J, Lynch S, Waubant E, US Network of Pediatric MS Centers. PMID: 27000242; PMCID: PMC4806409.
      View in: PubMed   Mentions: 96     Fields:    Translation:Humans
    220. The challenge of comorbidity in clinical trials for multiple sclerosis. Neurology. 2016 Apr 12; 86(15):1437-1445. Marrie RA, Miller A, Sormani MP, Thompson A, Waubant E, Trojano M, O'Connor P, Reingold S, Cohen JA, attendees of the International Workshop on Comorbidity in Multiple Sclerosis. PMID: 26888986; PMCID: PMC4831041.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    221. A case-control study of dietary salt intake in pediatric-onset multiple sclerosis. Mult Scler Relat Disord. 2016 Mar; 6:87-92. McDonald J, Graves J, Waldman A, Lotze T, Schreiner T, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema JM, Hart J, Lulu S, Ness J, Harris Y, Rubin J, Candee M, Krupp LB, Gorman M, Benson L, Rodriguez M, Chitnis T, Mar S, Barcellos LF, Laraia B, Rose J, Roalstad S, Simmons T, Casper TC, Waubant E. PMID: 27063630; PMCID: PMC4830915.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    222. Recommendations for observational studies of comorbidity in multiple sclerosis. Neurology. 2016 Apr 12; 86(15):1446-1453. Marrie RA, Miller A, Sormani MP, Thompson A, Waubant E, Trojano M, O'Connor P, Fiest K, Reider N, Reingold S, Cohen JA, attendees of the International Workshop on Comorbidity in Multiple Sclerosis. PMID: 26865523; PMCID: PMC4831039.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    223. Genetic predictors of relapse rate in pediatric MS. Mult Scler. 2016 10; 22(12):1528-1535. Graves JS, Barcellos LF, Shao X, Noble J, Mowry EM, Quach H, Belman A, Casper TC, Krupp LB, Waubant E, U.S. Network of Pediatric MS Centers. PMID: 26769066; PMCID: PMC4945462.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    224. Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report. Neurology. 2016 Jan 19; 86(3):245-52. Chitnis T, Ness J, Krupp L, Waubant E, Hunt T, Olsen CS, Rodriguez M, Lotze T, Gorman M, Benson L, Belman A, Weinstock-Guttman B, Aaen G, Graves J, Patterson M, Rose JW, Casper TC. PMID: 26683648; PMCID: PMC4733158.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    225. Acute Flaccid Myelitis of Unknown Etiology in California, 2012-2015. JAMA. 2015 Dec 22-29; 314(24):2663-71. Van Haren K, Ayscue P, Waubant E, Clayton A, Sheriff H, Yagi S, Glenn-Finer R, Padilla T, Strober JB, Aldrovandi G, Wadford DA, Chiu CY, Xia D, Harriman K, Watt JP, Glaser CA. PMID: 26720027.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansCells
    226. Association Between Glutamate Blockade and Fatigue in Patients With Multiple Sclerosis. JAMA Neurol. 2015 Nov; 72(11):1374-5. Nourbakhsh B, Revirajan N, Waubant E. PMID: 26551959.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    227. Longitudinal associations between MRI and cognitive changes in very early MS. Mult Scler Relat Disord. 2016 Jan; 5:47-52. Nourbakhsh B, Nunan-Saah J, Maghzi AH, Julian LJ, Spain R, Jin C, Lazar A, Pelletier D, Waubant E. PMID: 26856943.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    228. Longitudinal associations between brain structural changes and fatigue in early MS. Mult Scler Relat Disord. 2016 Jan; 5:29-33. Nourbakhsh B, Azevedo C, Nunan-Saah J, Maghzi AH, Spain R, Pelletier D, Waubant E. PMID: 26856940.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    229. Relapses in multiple sclerosis: Relationship to disability. Mult Scler Relat Disord. 2016 Mar; 6:10-20. Goodin DS, Reder AT, Bermel RA, Cutter GR, Fox RJ, John GR, Lublin FD, Lucchinetti CF, Miller AE, Pelletier D, Racke MK, Trapp BD, Vartanian T, Waubant E. PMID: 27063617.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    230. Multiple sclerosis patients have a diminished serologic response to vitamin D supplementation compared to healthy controls. Mult Scler. 2016 05; 22(6):753-60. Bhargava P, Steele SU, Waubant E, Revirajan NR, Marcus J, Dembele M, Cassard SD, Hollis BW, Crainiceanu C, Mowry EM. PMID: 26286698; PMCID: PMC4758937.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    231. Association Between Thoracic Spinal Cord Gray Matter Atrophy and Disability in Multiple Sclerosis. JAMA Neurol. 2015 Aug; 72(8):897-904. Schlaeger R, Papinutto N, Zhu AH, Lobach IV, Bevan CJ, Bucci M, Castellano A, Gelfand JM, Graves JS, Green AJ, Jordan KM, Keshavan A, Panara V, Stern WA, von Büdingen HC, Waubant E, Goodin DS, Cree BA, Hauser SL, Henry RG. PMID: 26053119; PMCID: PMC6002864.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    232. Update on biomarkers in neuromyelitis optica. Neurol Neuroimmunol Neuroinflamm. 2015 Aug; 2(4):e134. Melamed E, Levy M, Waters PJ, Sato DK, Bennett JL, John GR, Hooper DC, Saiz A, Bar-Or A, Kim HJ, Pandit L, Leite MI, Asgari N, Kissani N, Hintzen R, Marignier R, Jarius S, Marcelletti J, Smith TJ, Yeaman MR, Han MH, Aktas O, Apiwattanakul M, Banwell B, Bichuetti D, Broadley S, Cabre P, Chitnis T, De Seze J, Fujihara K, Greenberg B, Hellwig K, Iorio R, Jarius S, Klawiter E, Kleiter I, Lana-Peixoto M, O'Connor K, Palace J, Paul F, Prayoonwiwat N, Ruprecht K, Stuve O, Tedder T, Tenembaum S, Garrahan JP, Aires B, van Herle K, van Pelt D, Villoslada P, Waubant E, Weinshenker B, Wingerchuk D, Würfel J, Zamvil S. PMID: 26236760; PMCID: PMC4516398.
      View in: PubMed   Mentions: 50     Fields:    
    233. Neuropsychological correlates of multiple sclerosis across the lifespan. Mult Scler. 2015 Oct; 21(11):1355-64. Nunan-Saah J, Paulraj SR, Waubant E, Krupp LB, Gomez RG. PMID: 26163074.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    234. Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder. JAMA Neurol. 2015 Jul; 72(7):815-22. Kremer S, Renard F, Achard S, Lana-Peixoto MA, Palace J, Asgari N, Klawiter EC, Tenembaum SN, Banwell B, Greenberg BM, Bennett JL, Levy M, Villoslada P, Saiz A, Fujihara K, Chan KH, Schippling S, Paul F, Kim HJ, de Seze J, Wuerfel JT, Guthy-Jackson Charitable Foundation (GJCF) Neuromyelitis Optica (NMO) International Clinical Consort, Cabre P, Marignier R, Tedder T, van Pelt D, Broadley S, Chitnis T, Wingerchuk D, Pandit L, Leite MI, Apiwattanakul M, Kleiter I, Prayoonwiwat N, Han M, Hellwig K, van Herle K, John G, Hooper DC, Nakashima I, Sato D, Yeaman MR, Waubant E, Zamvil S, Stüve O, Aktas O, Smith TJ, Jacob A, O'Connor K. PMID: 26010909; PMCID: PMC4828237.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    235. Gut microbiota in multiple sclerosis: possible influence of immunomodulators. J Investig Med. 2015 Jun; 63(5):729-34. Cantarel BL, Waubant E, Chehoud C, Kuczynski J, DeSantis TZ, Warrington J, Venkatesan A, Fraser CM, Mowry EM. PMID: 25775034; PMCID: PMC4439263.
      View in: PubMed   Mentions: 213     Fields:    Translation:Humans
    236. Menarche increases relapse risk in pediatric multiple sclerosis. Mult Scler. 2016 Feb; 22(2):193-200. Lulu S, Graves J, Waubant E. PMID: 25948626; PMCID: PMC4636485.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    237. Retinal axonal loss in very early stages of multiple sclerosis. Eur J Neurol. 2015 Jul; 22(7):1138-41. Maghzi AH, Graves J, Revirajan N, Spain R, Liu S, McCulloch CE, Pelletier D, Green AJ, Waubant E. PMID: 25929276.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    238. Patient preferences for attributes of multiple sclerosis disease-modifying therapies: development and results of a ratings-based conjoint analysis. Int J MS Care. 2015 Mar-Apr; 17(2):74-82. Wilson LS, Loucks A, Gipson G, Zhong L, Bui C, Miller E, Owen M, Pelletier D, Goodin D, Waubant E, McCulloch CE. PMID: 25892977; PMCID: PMC4399770.
      View in: PubMed   Mentions: 43  
    239. Prolonged Remission in Neuromyelitis Optica Following Cessation of Rituximab Treatment. J Child Neurol. 2015 Sep; 30(10):1366-70. Weinfurtner K, Graves J, Ness J, Krupp L, Milazzo M, Waubant E. PMID: 25387545.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    240. Treatment adherence and transitioning youth in pediatric multiple sclerosis. Mult Scler Relat Disord. 2014 Nov; 3(6):689-95. Lulu S, Julian L, Shapiro E, Hudson K, Waubant E. PMID: 25798373; PMCID: PMC4361811.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    241. Protective environmental factors for neuromyelitis optica. Neurology. 2014 Nov 18; 83(21):1923-9. Graves J, Grandhe S, Weinfurtner K, Krupp L, Belman A, Chitnis T, Ness J, Weinstock-Guttman B, Gorman M, Patterson M, Rodriguez M, Lotze T, Aaen G, Mowry EM, Rose JW, Simmons T, Casper TC, James J, Waubant E, US Network of Pediatric Multiple Sclerosis Centers. PMID: 25339213; PMCID: PMC4248458.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    242. Precision medicine in chronic disease management: The multiple sclerosis BioScreen. Ann Neurol. 2014 Nov; 76(5):633-42. Gourraud PA, Henry RG, Cree BA, Crane JC, Lizee A, Olson MP, Santaniello AV, Datta E, Zhu AH, Bevan CJ, Gelfand JM, Graves JS, Goodin DS, Green AJ, von Büdingen HC, Waubant E, Zamvil SS, Crabtree-Hartman E, Nelson S, Baranzini SE, Hauser SL. PMID: 25263997; PMCID: PMC4214886.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    243. The vitamin D to ameliorate multiple sclerosis (VIDAMS) trial: study design for a multicenter, randomized, double-blind controlled trial of vitamin D in multiple sclerosis. Contemp Clin Trials. 2014 Nov; 39(2):288-93. Bhargava P, Cassard S, Steele SU, Azevedo C, Pelletier D, Sugar EA, Waubant E, Mowry EM. PMID: 25311447.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    244. Acute flaccid paralysis with anterior myelitis - California, June 2012-June 2014. MMWR Morb Mortal Wkly Rep. 2014 Oct 10; 63(40):903-6. Ayscue P, Van Haren K, Sheriff H, Waubant E, Waldron P, Yagi S, Yen C, Clayton A, Padilla T, Pan C, Reichel J, Harriman K, Watt J, Sejvar J, Nix WA, Feikin D, Glaser C, Centers for Disease Control and Prevention (CDC). PMID: 25299608; PMCID: PMC4584614.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    245. The US Network of Pediatric Multiple Sclerosis Centers: Development, Progress, and Next Steps. J Child Neurol. 2015 Sep; 30(10):1381-7. Casper TC, Rose JW, Roalstad S, Waubant E, Aaen G, Belman A, Chitnis T, Gorman M, Krupp L, Lotze TE, Ness J, Patterson M, Rodriguez M, Weinstock-Guttman B, Browning B, Graves J, Tillema JM, Benson L, Harris Y, US Network of Pediatric Multiple Sclerosis Centers. PMID: 25270659; PMCID: PMC4379142.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    246. Spinal cord gray matter atrophy correlates with multiple sclerosis disability. Ann Neurol. 2014 Oct; 76(4):568-80. Schlaeger R, Papinutto N, Panara V, Bevan C, Lobach IV, Bucci M, Caverzasi E, Gelfand JM, Green AJ, Jordan KM, Stern WA, von Büdingen HC, Waubant E, Zhu AH, Goodin DS, Cree BA, Hauser SL, Henry RG. PMID: 25087920; PMCID: PMC5316412.
      View in: PubMed   Mentions: 97     Fields:    Translation:Humans
    247. Magnetic resonance imaging correlates of clinical outcomes in early multiple sclerosis. Mult Scler Relat Disord. 2014 Nov; 3(6):720-7. Maghzi AH, Revirajan N, Julian LJ, Spain R, Mowry EM, Liu S, Jin C, Green AJ, McCulloch CE, Pelletier D, Waubant E. PMID: 25891551.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    248. Patient centered decision making: use of conjoint analysis to determine risk-benefit trade-offs for preference sensitive treatment choices. J Neurol Sci. 2014 Sep 15; 344(1-2):80-7. Wilson L, Loucks A, Bui C, Gipson G, Zhong L, Schwartzburg A, Crabtree E, Goodin D, Waubant E, McCulloch C. PMID: 25037284.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    249. B-cell depletion in children with neuroimmunologic conditions: the learning curve. Neurology. 2014 Jul 08; 83(2):111-2. Chitnis T, Waubant E. PMID: 24920852.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    250. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology. 2014 Jul 15; 83(3):278-86. Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sørensen PS, Thompson AJ, Wolinsky JS, Balcer LJ, Banwell B, Barkhof F, Bebo B, Calabresi PA, Clanet M, Comi G, Fox RJ, Freedman MS, Goodman AD, Inglese M, Kappos L, Kieseier BC, Lincoln JA, Lubetzki C, Miller AE, Montalban X, O'Connor PW, Petkau J, Pozzilli C, Rudick RA, Sormani MP, Stüve O, Waubant E, Polman CH. PMID: 24871874; PMCID: PMC4117366.
      View in: PubMed   Mentions: 1286     Fields:    Translation:Humans
    251. A randomized controlled phase II trial of riluzole in early multiple sclerosis. Ann Clin Transl Neurol. 2014 May; 1(5):340-7. Waubant E, Maghzi AH, Revirajan N, Spain R, Julian L, Mowry EM, Marcus J, Liu S, Jin C, Green A, McCulloch CE, Pelletier D. PMID: 25356404; PMCID: PMC4184685.
      View in: PubMed   Mentions: 16     Fields:    
    252. Atypical cases of scleroderma en coup de sabre. J Child Neurol. 2014 May; 29(5):698-703. Kraus V, Lawson EF, von Scheven E, Tihan T, Garza J, Nathan RG, Cordoro KM, Waubant E. PMID: 24667737.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    253. Longitudinally extensive optic neuritis in pediatric patients. J Child Neurol. 2015 Jan; 30(1):120-3. Graves J, Kraus V, Soares BP, Hess CP, Waubant E. PMID: 24563470.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    254. Rituximab use in pediatric central demyelinating disease. Pediatr Neurol. 2014 Jul; 51(1):114-8. Beres SJ, Graves J, Waubant E. PMID: 24768216.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    255. MS and related disorders: groundbreaking news. Lancet Neurol. 2014 Jan; 13(1):11-3. Waubant E, Cross A. PMID: 24331785.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    256. Quantitative MRI analysis in children with multiple sclerosis: a multicenter feasibility pilot study. BMC Neurol. 2013 Nov 13; 13:173. Chitnis T, Guttmann CR, Zaitsev A, Musallam A, Weinstock-Guttman B, Yeh A, Rodriguez M, Ness J, Gorman MP, Healy BC, Kuntz N, Chabas D, Strober JB, Waubant E, Krupp L, Pelletier D, Erickson B, Bergsland N, Zivadinov R, U.S. Network of Pediatric MS Centers of Excellence. PMID: 24225378; PMCID: PMC3832402.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    257. Effects of rituximab on lymphocytes in multiple sclerosis and neuromyelitis optica. Mult Scler Relat Disord. 2014 Mar; 3(2):244-52. Graves J, Vinayagasundaram U, Mowry EM, Matthews IR, Marino JA, Cheng J, Waubant E. PMID: 25878012.
      View in: PubMed   Mentions: 20     Fields:    
    258. Association of multiple sclerosis susceptibility variants and early attack location in the CNS. PLoS One. 2013; 8(10):e75565. Mowry EM, Carey RF, Blasco MR, Pelletier J, Duquette P, Villoslada P, Malikova I, Roger E, Kinkel RP, McDonald J, Bacchetti P, Waubant E. PMID: 24130718; PMCID: PMC3794979.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    259. Multiple sclerosis susceptibility genes: associations with relapse severity and recovery. PLoS One. 2013; 8(10):e75416. Mowry EM, Carey RF, Blasco MR, Pelletier J, Duquette P, Villoslada P, Malikova I, Roger E, Kinkel RP, McDonald J, Bacchetti P, Waubant E. PMID: 24130709; PMCID: PMC3793991.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    260. Neuroprotection in multiple sclerosis: a therapeutic approach. CNS Drugs. 2013 Oct; 27(10):799-815. Maghzi AH, Minagar A, Waubant E. PMID: 23955320.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    261. Rituximab in relapsing and progressive forms of multiple sclerosis: a systematic review. PLoS One. 2013; 8(7):e66308. Castillo-Trivino T, Braithwaite D, Bacchetti P, Waubant E. PMID: 23843952; PMCID: PMC3699597.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    262. Therapeutic advances in pediatric multiple sclerosis. J Pediatr. 2013 Sep; 163(3):631-7. Van Haren K, Waubant E. PMID: 23726542.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    263. Updates on clinically isolated syndrome and diagnostic criteria for multiple sclerosis. Neurohospitalist. 2013 Apr; 3(2):65-80. Marcus JF, Waubant EL. PMID: 23983889; PMCID: PMC3726117.
      View in: PubMed   Mentions: 11  
    264. International Pediatric MS Study Group Clinical Trials Summit: meeting report. Neurology. 2013 Mar 19; 80(12):1161-8. Chitnis T, Tardieu M, Amato MP, Banwell B, Bar-Or A, Ghezzi A, Kornberg A, Krupp LB, Pohl D, Rostasy K, Tenembaum S, Waubant E, Wassmer E. PMID: 23509048; PMCID: PMC3662305.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    265. Humoral-targeted immunotherapies in multiple sclerosis. Neurotherapeutics. 2013 Jan; 10(1):34-43. Lulu S, Waubant E. PMID: 23208729; PMCID: PMC3557366.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    266. Copy number variation in pediatric multiple sclerosis. Mult Scler. 2013 Jul; 19(8):1014-21. McElroy JP, Krupp LB, Johnson BA, McCauley JL, Qi Z, Caillier SJ, Gourraud PA, Yu J, Nathanson L, Belman AL, Hauser SL, Waubant E, Hedges DJ, Oksenberg JR. PMID: 23239789; PMCID: PMC5507577.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    267. Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis. Mult Scler. 2013 Jun; 19(7):891-5. Waubant E, Mowry EM, Krupp L, Chitnis T, Yeh EA, Kuntz N, Ness J, Belman A, Milazzo M, Gorman M, Weinstock-Guttman B, Rodriguez M, James JA. PMID: 23232601; PMCID: PMC3665694.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    268. Cognitive impairment occurs in children and adolescents with multiple sclerosis: results from a United States network. J Child Neurol. 2013 Jan; 28(1):102-7. Julian L, Serafin D, Charvet L, Ackerson J, Benedict R, Braaten E, Brown T, O'Donnell E, Parrish J, Preston T, Zaccariello M, Belman A, Chitnis T, Gorman M, Ness J, Patterson M, Rodriguez M, Waubant E, Weinstock-Guttman B, Yeh A, Krupp LB, Network of Pediatric MS Centers of Excellence. PMID: 23155206; PMCID: PMC3652651.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    269. Treatment of Neuromyelitis Optica: Review and Recommendations. Mult Scler Relat Disord. 2012 Oct; 1(4):180-187. Kimbrough DJ, Fujihara K, Jacob A, Lana-Peixoto MA, Leite MI, Levy M, Marignier R, Nakashima I, Palace J, de Seze J, Stuve O, Tenembaum SN, Traboulsee A, Waubant E, Weinshenker BG, Wingerchuk DM, GJCF-CC&BR. PMID: 24555176; PMCID: PMC3926208.
      View in: PubMed   Mentions: 93     Fields:    
    270. EDSS variability before randomization may limit treatment discovery in primary progressive MS. Mult Scler. 2013 May; 19(6):775-81. Zhang J, Waubant E, Cutter G, Wolinsky JS, Glanzman R. PMID: 23027880.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    271. Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis. Ann Neurol. 2012 Aug; 72(2):234-40. Mowry EM, Waubant E, McCulloch CE, Okuda DT, Evangelista AA, Lincoln RR, Gourraud PA, Brenneman D, Owen MC, Qualley P, Bucci M, Hauser SL, Pelletier D. PMID: 22926855; PMCID: PMC3430977.
      View in: PubMed   Mentions: 102     Fields:    Translation:Humans
    272. Antibodies to potassium channels in multiple sclerosis. N Engl J Med. 2012 Jul 12; 367(2):172-4. Cross AH, Waubant E. PMID: 22784120.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    273. Overview of treatment options in multiple sclerosis. J Clin Psychiatry. 2012 Jun; 73(6):e22. Waubant E. PMID: 22795209.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    274. Early recognition and diagnosis of multiple sclerosis. J Clin Psychiatry. 2012 Apr; 73(4):e14. Waubant E. PMID: 22579157.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    275. Randomized controlled trial of atorvastatin in clinically isolated syndrome: the STAyCIS study. Neurology. 2012 Apr 10; 78(15):1171-8. Waubant E, Pelletier D, Mass M, Cohen JA, Kita M, Cross A, Bar-Or A, Vollmer T, Racke M, Stüve O, Schwid S, Goodman A, Kachuck N, Preiningerova J, Weinstock-Guttman B, Calabresi PA, Miller A, Mokhtarani M, Iklé D, Murphy S, Kopetskie H, Ding L, Rosenberg E, Spencer C, Zamvil SS, ITN STAyCIS Study Group, ITN020AI Study Management Team. PMID: 22459680; PMCID: PMC3320055.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCTClinical Trials
    276. Unilateral thalamic deep brain stimulation for disabling kinetic tremor in multiple sclerosis. Neurosurgery. 2012 Jan; 70(1):66-9. Hosseini H, Mandat T, Waubant E, Agid Y, Lubetzki C, Lyon-Caen O, Stankoff B, Jedynak P, Cesaro P, Palfi S, Nguyen JP. PMID: 21768914.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    277. Relapse severity and recovery in early pediatric multiple sclerosis. Mult Scler. 2012 Jul; 18(7):1008-12. Fay AJ, Mowry EM, Strober J, Waubant E. PMID: 22183939.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    278. Incidence of acquired CNS demyelinating syndromes in a multiethnic cohort of children. Neurology. 2011 Sep 20; 77(12):1143-8. Langer-Gould A, Zhang JL, Chung J, Yeung Y, Waubant E, Yao J. PMID: 21865580; PMCID: PMC3265045.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansPHPublic Health
    279. Consensus Guidelines for CSF and Blood Biobanking for CNS Biomarker Studies. Mult Scler Int. 2011; 2011:246412. Teunissen CE, Tumani H, Bennett JL, Berven FS, Brundin L, Comabella M, Franciotta D, Federiksen JL, Fleming JO, Furlan R, Hintzen RQ, Hughes SG, Jimenez CR, Johnson MH, Killestein J, Krasulova E, Kuhle J, Magnone MC, Petzold A, Rajda C, Rejdak K, Schmidt HK, van Pesch V, Waubant E, Wolf C, Deisenhammer F, Giovannoni G, Hemmer B. PMID: 22096631; PMCID: PMC3195993.
      View in: PubMed   Mentions: 29  
    280. Common viruses associated with lower pediatric multiple sclerosis risk. Neurology. 2011 Jun 07; 76(23):1989-95. Waubant E, Mowry EM, Krupp L, Chitnis T, Yeh EA, Kuntz N, Ness J, Chabas D, Strober J, McDonald J, Belman A, Milazzo M, Gorman M, Weinstock-Guttman B, Rodriguez M, Oksenberg JR, James JA, US Pediatric MS Network. PMID: 21646624; PMCID: PMC3109881.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    281. Preface: multiple sclerosis in the 21st century. Neurol Clin. 2011 May; 29(2):xiii-xiv. Waubant EL. PMID: 21439436.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    282. Pediatric multiple sclerosis. Neurol Clin. 2011 May; 29(2):481-505. Chitnis T, Krupp L, Yeh A, Rubin J, Kuntz N, Strober JB, Chabas D, Weinstock-Guttmann B, Ness J, Rodriguez M, Waubant E. PMID: 21439455.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    283. Switching multiple sclerosis patients with breakthrough disease to second-line therapy. PLoS One. 2011 Feb 03; 6(2):e16664. Castillo-Trivino T, Mowry EM, Gajofatto A, Chabas D, Crabtree-Hartman E, Cree BA, Goodin DS, Green AJ, Okuda DT, Pelletier D, Zamvil SS, Vittinghoff E, Waubant E. PMID: 21304907; PMCID: PMC3033401.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    284. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011 Feb; 69(2):292-302. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O'Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS. PMID: 21387374; PMCID: PMC3084507.
      View in: PubMed   Mentions: 3523     Fields:    Translation:Humans
    285. Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome. Neurology. 2011 Feb 22; 76(8):686-92. Okuda DT, Mowry EM, Cree BA, Crabtree EC, Goodin DS, Waubant E, Pelletier D. PMID: 21270417; PMCID: PMC3053327.
      View in: PubMed   Mentions: 88     Fields:    Translation:Humans
    286. Vitamin D status and antibody levels to common viruses in pediatric-onset multiple sclerosis. Mult Scler. 2011 Jun; 17(6):666-71. Mowry EM, James JA, Krupp LB, Waubant E. PMID: 21212086; PMCID: PMC3134182.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    287. Multiple sclerosis therapies in pediatric patients with refractory multiple sclerosis. Arch Neurol. 2011 Apr; 68(4):437-44. Yeh EA, Waubant E, Krupp LB, Ness J, Chitnis T, Kuntz N, Ramanathan M, Belman A, Chabas D, Gorman MP, Rodriguez M, Rinker JR, Weinstock-Guttman B, National Network of Pediatric MS Centers of Excellence. PMID: 21149803.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    288. Pediatric multiple sclerosis. Continuum (Minneap Minn). 2010 Oct; 16(5 Multiple Sclerosis):181-92. Mowry EM, Waubant E. PMID: 22810605.
      View in: PubMed   Mentions: 1     Fields:    
    289. Health-related quality of life is reduced in pediatric multiple sclerosis. Pediatr Neurol. 2010 Aug; 43(2):97-102. Mowry EM, Julian LJ, Im-Wang S, Chabas D, Galvin AJ, Strober JB, Waubant E. PMID: 20610119.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    290. MS and the B cell controversy. Biochim Biophys Acta. 2011 Feb; 1812(2):231-8. Cross AH, Waubant E. PMID: 20674743.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    291. Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis. Ann Neurol. 2010 May; 67(5):618-24. Mowry EM, Krupp LB, Milazzo M, Chabas D, Strober JB, Belman AL, McDonald JC, Oksenberg JR, Bacchetti P, Waubant E. PMID: 20437559.
      View in: PubMed   Mentions: 127     Fields:    Translation:Humans
    292. Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS? Ann Neurol. 2010 Apr; 67(4):452-61. Bar-Or A, Fawaz L, Fan B, Darlington PJ, Rieger A, Ghorayeb C, Calabresi PA, Waubant E, Hauser SL, Zhang J, Smith CH. PMID: 20437580.
      View in: PubMed   Mentions: 268     Fields:    Translation:HumansCellsCTClinical Trials
    293. Treatment of multiple sclerosis in children and adolescents. Expert Opin Pharmacother. 2010 Mar; 11(4):505-20. Kuntz NL, Chabas D, Weinstock-Guttman B, Chitnis T, Yeh EA, Krupp L, Ness J, Rodriguez M, Waubant E, Network of US Pediatric Multiple Sclerosis Centers. PMID: 20163265.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    294. Younger children with MS have a distinct CSF inflammatory profile at disease onset. Neurology. 2010 Feb 02; 74(5):399-405. Chabas D, Ness J, Belman A, Yeh EA, Kuntz N, Gorman MP, Strober JB, De Kouchkovsky I, McCulloch C, Chitnis T, Rodriguez M, Weinstock-Guttman B, Krupp LB, Waubant E, US Network of Pediatric MS Centers of Excellence. PMID: 20124205; PMCID: PMC2816008.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    295. Does race matter for multiple sclerosis? Neurology. 2010 Feb 16; 74(7):532-3. Cree B, Waubant E. PMID: 20089941.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    296. Pediatric multiple sclerosis. Nat Rev Neurol. 2009 Nov; 5(11):621-31. Yeh EA, Chitnis T, Krupp L, Ness J, Chabas D, Kuntz N, Waubant E, US Network of Pediatric Multiple Sclerosis Centers of Excellence. PMID: 19826402.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCells
    297. Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial. Ann Neurol. 2009 Oct; 66(4):460-71. Hawker K, O'Connor P, Freedman MS, Calabresi PA, Antel J, Simon J, Hauser S, Waubant E, Vollmer T, Panitch H, Zhang J, Chin P, Smith CH, OLYMPUS trial group. PMID: 19847908.
      View in: PubMed   Mentions: 390     Fields:    Translation:HumansCTClinical Trials
    298. Difference in disease burden and activity in pediatric patients on brain magnetic resonance imaging at time of multiple sclerosis onset vs adults. Arch Neurol. 2009 Aug; 66(8):967-71. Waubant E, Chabas D, Okuda DT, Glenn O, Mowry E, Henry RG, Strober JB, Soares B, Wintermark M, Pelletier D. PMID: 19667217.
      View in: PubMed   Mentions: 63     Fields:    Translation:Humans
    299. Absence of neuromyelitis optica IgG antibody in an active relapsing-remitting multiple sclerosis population. J Neuroophthalmol. 2009 Jun; 29(2):104-6. Smith CH, Waubant E, Langer-Gould A. PMID: 19491632.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    300. Quality of life in multiple sclerosis is associated with lesion burden and brain volume measures. Neurology. 2009 May 19; 72(20):1760-5. Mowry EM, Beheshtian A, Waubant E, Goodin DS, Cree BA, Qualley P, Lincoln R, George MF, Gomez R, Hauser SL, Okuda DT, Pelletier D. PMID: 19451531; PMCID: PMC2683738.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    301. Pediatric multiple sclerosis. Curr Treat Options Neurol. 2009 May; 11(3):203-10. Waubant E, Chabas D. PMID: 19364455.
      View in: PubMed   Mentions: 10  
    302. Clinical predictors of early second event in patients with clinically isolated syndrome. J Neurol. 2009 Jul; 256(7):1061-6. Mowry EM, Pesic M, Grimes B, Deen SR, Bacchetti P, Waubant E. PMID: 19252775; PMCID: PMC2708331.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    303. Demyelinating events in early multiple sclerosis have inherent severity and recovery. Neurology. 2009 Feb 17; 72(7):602-8. Mowry EM, Pesic M, Grimes B, Deen S, Bacchetti P, Waubant E. PMID: 19221292; PMCID: PMC2677540.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    304. Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. Neurology. 2009 Mar 03; 72(9):800-5. Okuda DT, Mowry EM, Beheshtian A, Waubant E, Baranzini SE, Goodin DS, Hauser SL, Pelletier D. PMID: 19073949.
      View in: PubMed   Mentions: 196     Fields:    Translation:Humans
    305. The onset location of multiple sclerosis predicts the location of subsequent relapses. J Neurol Neurosurg Psychiatry. 2009 Apr; 80(4):400-3. Mowry EM, Deen S, Malikova I, Pelletier J, Bacchetti P, Waubant E. PMID: 19066192.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    306. Genotype-Phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures. Brain. 2009 Jan; 132(Pt 1):250-9. Okuda DT, Srinivasan R, Oksenberg JR, Goodin DS, Baranzini SE, Beheshtian A, Waubant E, Zamvil SS, Leppert D, Qualley P, Lincoln R, Gomez R, Caillier S, George M, Wang J, Nelson SJ, Cree BA, Hauser SL, Pelletier D. PMID: 19022862; PMCID: PMC2638695.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    307. Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet. 2009 Feb 15; 18(4):767-78. Baranzini SE, Wang J, Gibson RA, Galwey N, Naegelin Y, Barkhof F, Radue EW, Lindberg RL, Uitdehaag BM, Johnson MR, Angelakopoulou A, Hall L, Richardson JC, Prinjha RK, Gass A, Geurts JJ, Kragt J, Sombekke M, Vrenken H, Qualley P, Lincoln RR, Gomez R, Caillier SJ, George MF, Mousavi H, Guerrero R, Okuda DT, Cree BA, Green AJ, Waubant E, Goodin DS, Pelletier D, Matthews PM, Hauser SL, Kappos L, Polman CH, Oksenberg JR. PMID: 19010793; PMCID: PMC4334814.
      View in: PubMed   Mentions: 214     Fields:    Translation:Humans
    308. Switching first-line disease-modifying therapy after failure: impact on the course of relapsing-remitting multiple sclerosis. Mult Scler. 2009 Jan; 15(1):50-8. Gajofatto A, Bacchetti P, Grimes B, High A, Waubant E. PMID: 18922831.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    309. Vanishing MS T2-bright lesions before puberty: a distinct MRI phenotype? Neurology. 2008 Sep 30; 71(14):1090-3. Chabas D, Castillo-Trivino T, Mowry EM, Strober JB, Glenn OA, Waubant E. PMID: 18824673.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    310. Pediatric multiple sclerosis. Curr Neurol Neurosci Rep. 2008 Sep; 8(5):434-41. Chabas D, Strober J, Waubant E. PMID: 18713581.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    311. Spotlight on anti-CD20. Int MS J. 2008 Mar; 15(1):19-25. Waubant E. PMID: 18713565.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    312. Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial. Ann Neurol. 2008 Mar; 63(3):395-400. Bar-Or A, Calabresi PA, Arnold D, Arnlod D, Markowitz C, Shafer S, Kasper LH, Waubant E, Gazda S, Fox RJ, Panzara M, Sarkar N, Agarwal S, Smith CH. PMID: 18383069.
      View in: PubMed   Mentions: 243     Fields:    Translation:HumansCellsCTClinical Trials
    313. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med. 2008 Feb 14; 358(7):676-88. Hauser SL, Waubant E, Arnold DL, Vollmer T, Antel J, Fox RJ, Bar-Or A, Panzara M, Sarkar N, Agarwal S, Langer-Gould A, Smith CH, HERMES Trial Group. PMID: 18272891.
      View in: PubMed   Mentions: 1030     Fields:    Translation:HumansCellsCTClinical Trials
    314. Predictors of the location of multiple sclerosis relapse. J Neurol Neurosurg Psychiatry. 2008 Oct; 79(10):1190-3. Deen S, Bacchetti P, High A, Waubant E. PMID: 18223021.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    315. Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study. Lancet Neurol. 2007 Sep; 6(9):773-81. Banwell B, Krupp L, Kennedy J, Tellier R, Tenembaum S, Ness J, Belman A, Boiko A, Bykova O, Waubant E, Mah JK, Stoian C, Kremenchutzky M, Bardini MR, Ruggieri M, Rensel M, Hahn J, Weinstock-Guttman B, Yeh EA, Farrell K, Freedman M, Iivanainen M, Sevon M, Bhan V, Dilenge ME, Stephens D, Bar-Or A. PMID: 17689148.
      View in: PubMed   Mentions: 114     Fields:    Translation:HumansCells
    316. Identification of short-term pharmacodynamic effects of interferon-beta-1a in multiple sclerosis subjects with broad- based phenotypic profiling. J Neuroimmunol. 2007 Aug; 188(1-2):103-16. Kantor AB, Deng J, Waubant E, Lin H, Becker CH, Lacy JR, Perrone AM, Bennett D, Goelz SE. PMID: 17614141.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCellsCTClinical Trials
    317. Emerging therapies for MS. Rev Neurol (Paris). 2007 Jun; 163(6-7):688-96. Waubant E. PMID: 17607191.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    318. Challenges in the classification of pediatric multiple sclerosis and future directions. Neurology. 2007 Apr 17; 68(16 Suppl 2):S70-4. Belman AL, Chitnis T, Renoux C, Waubant E, International Pediatric MS Study Group. PMID: 17438242.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    319. Are initial demyelinating event recovery and time to second event under differential control? Neurology. 2006 Sep 12; 67(5):809-13. West T, Wyatt M, High A, Bostrom A, Waubant E. PMID: 16966542.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    320. Pediatric multiple sclerosis. NeuroRx. 2006 Apr; 3(2):264-75. Chabas D, Green AJ, Waubant E. PMID: 16554264; PMCID: PMC3593440.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    321. Biomarkers indicative of blood-brain barrier disruption in multiple sclerosis. Dis Markers. 2006; 22(4):235-44. Waubant E. PMID: 17124345; PMCID: PMC3850823.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    322. Acute pathological laughter. Mov Disord. 2005 Oct; 20(10):1389-90. Okuda DT, Chyung AS, Chin CT, Waubant E. PMID: 16007658.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    323. Interferon beta babies. Neurology. 2005 Sep 27; 65(6):788-9. Waubant E, Sadovnick AD. PMID: 16186513.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    324. An open label study of the effects of rituximab in neuromyelitis optica. Neurology. 2005 Apr 12; 64(7):1270-2. Cree BA, Lamb S, Morgan K, Chen A, Waubant E, Genain C. PMID: 15824362.
      View in: PubMed   Mentions: 198     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    325. Multiple sclerosis tremor and the Stewart-Holmes manoeuvre. Mov Disord. 2003 Aug; 18(8):948-52. Waubant E, Tezenas du Montcel S, Jedynak C, Obadia M, Hosseini H, Damier P, Lubetzki C, Agid Y, Degos JD. PMID: 12889088.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    326. Clinical characteristics of responders to interferon therapy for relapsing MS. Neurology. 2003 Jul 22; 61(2):184-9. Waubant E, Vukusic S, Gignoux L, Dubief FD, Achiti I, Blanc S, Renoux C, Confavreux C. PMID: 12874396.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    327. Emerging disease modifying therapies for multiple sclerosis. Expert Opin Emerg Drugs. 2003 May; 8(1):145-61. Waubant E. PMID: 14610918.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    328. IFNbeta lowers MMP-9/TIMP-1 ratio, which predicts new enhancing lesions in patients with SPMS. Neurology. 2003 Jan 14; 60(1):52-7. Waubant E, Goodkin D, Bostrom A, Bacchetti P, Hietpas J, Lindberg R, Leppert D. PMID: 12525717.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCTClinical Trials
    329. Interferon beta-1a in children with multiple sclerosis is well tolerated. Neuropediatrics. 2001 Aug; 32(4):211-3. Waubant E, Hietpas J, Stewart T, Dyme Z, Herbert J, Lacy J, Miller C, Rensel M, Schwid S, Goodkin D. PMID: 11571702.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    330. IFN-beta1a may increase serum levels of TIMP-1 in patients with relapsing-remitting multiple sclerosis. J Interferon Cytokine Res. 2001 Mar; 21(3):181-5. Waubant E, Gee L, Miller K, Stabler G, Goodkin D. PMID: 11331041.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    331. Relationship between serum levels of IL-10, MRI activity and interferon beta-1a therapy in patients with relapsing remitting MS. J Neuroimmunol. 2001 Jan 01; 112(1-2):139-45. Waubant E, Gee L, Bacchetti P, Sloan R, Cotleur A, Rudick R, Goodkin D. PMID: 11108942.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    332. 1H MRSI comparison of white matter and lesions in primary progressive and relapsing-remitting MS. Mult Scler. 2000 Jun; 6(3):148-55. Suhy J, Rooney WD, Goodkin DE, Capizzano AA, Soher BJ, Maudsley AA, Waubant E, Andersson PB, Weiner MW. PMID: 10871825; PMCID: PMC2733351.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    333. Magnetization transfer ratio in new MS lesions before and during therapy with IFNbeta-1a. Neurology. 2000 May 09; 54(9):1741-5. Kita M, Goodkin DE, Bacchetti P, Waubant E, Nelson SJ, Majumdar S. PMID: 10802778.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    334. A phase I trial of solubilized DR2:MBP84-102 (AG284) in multiple sclerosis. Neurology. 2000 Apr 11; 54(7):1414-20. Goodkin DE, Shulman M, Winkelhake J, Waubant E, Andersson P, Stewart T, Nelson S, Fischbein N, Coyle PK, Frohman E, Jacobs L, Holcenberg J, Lee M, Mocci S. PMID: 10751249.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCellsCTClinical Trials
    335. Methodological problems in evaluating efficacy of a treatment in multiple sclerosis. Pathol Biol (Paris). 2000 Mar; 48(2):104-13. Waubant E, Goodkin D. PMID: 10815286.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    336. Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis. Neurology. 1999 Oct 22; 53(7):1397-401. Waubant E, Goodkin DE, Gee L, Bacchetti P, Sloan R, Stewart T, Andersson PB, Stabler G, Miller K. PMID: 10534241.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    337. A pilot study of MRI activity before and during interferon beta-1a therapy. Neurology. 1999 Sep 11; 53(4):874-6. Waubant E, Goodkin DE, Sloan R, Andersson PB. PMID: 10489060.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    338. Multiple sclerosis that is progressive from the time of onset: clinical characteristics and progression of disability. Arch Neurol. 1999 Sep; 56(9):1138-42. Andersson PB, Waubant E, Gee L, Goodkin DE. PMID: 10488816.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    339. [How phase III therapeutic trials in multiple sclerosis should be evaluated: advances and challenges]. Rev Neurol (Paris). 1999; 155 Suppl 2:S7-12. Waubant E, Goodkin D. PMID: 10367319.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    340. [Effect of weekly intramuscular interferon beta-1a on MRI lesions in patients with relapsing multiple sclerosis]. Rev Neurol (Paris). 1999; 155 Suppl 2:S20-3. Waubant E, Sloan R, Andersson PB, Goodkin D. PMID: 10367321.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    341. A serial study of new MS lesions and the white matter from which they arise. Neurology. 1998 Dec; 51(6):1689-97. Goodkin DE, Rooney WD, Sloan R, Bacchetti P, Gee L, Vermathen M, Waubant E, Abundo M, Majumdar S, Nelson S, Weiner MW. PMID: 9855524.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCells
    342. Cervical cord glioma in an HIV-positive patient. Eur Neurol. 1998; 39(1):58-60. Waubant E, Delisle MB, Bonafé A, Gray F, Clanet M. PMID: 9476726.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    343. How should we proceed with disease-modifying treatments for multiple sclerosis? Lancet. 1997 Mar 01; 349(9052):586-7. Andersson PB, Waubant E, Goodkin DE. PMID: 9057726.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    344. T cell gelatinases mediate basement membrane transmigration in vitro. J Immunol. 1995 May 01; 154(9):4379-89. Leppert D, Waubant E, Galardy R, Bunnett NW, Hauser SL. PMID: 7722295.
      View in: PubMed   Mentions: 86     Fields:    Translation:HumansCells
    Emmanuelle's Networks
    Concepts (597)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (73)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-40-gb10dcd06 on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.